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Summary 
In radiotherapy treatment, an amorphous silicon electronic portal imaging device (a-Si 
EPID) is mounted to the linear accelerator and is routinely used to verify patient setup prior to 
treatment. EPIDs have garnered much research interest for their important clinical applications 
and advantageous features, such as high resolution and fast acquisition times. As well, EPIDs offer 
the potential for “free” transit dosimetry and simply detect the treatment beam, meaning that the 
patient receives no additional dose. However, experience with EPIDs for transit dosimetry 
applications in the clinical setting is partially limited because of the complexity of reproducing the 
published methods. Commercial solutions have been presented and are continuing to emerge but 
are not mature enough for widespread adoption. The goal of this project was to extend the 
application of EPIDs in two main clinical areas, with the overall goal of providing a simple 
procedure that uses minimal resources. The EPID was used in transit dosimetry and in measuring 
beam attenuation through couch and immobilization devices. 
For the first investigation, the modern delivery modalities can change the dose rate during 
delivery or can deliver a low monitor unit (MU). Therefore, the influence of the cine mode 
dosimetric characteristics of the EPID were examined. Emphasis was placed on delivering a low 
MU and changing the dose rates. The EPID’s performance was then compared to the well-
documented integrated mode and dose measurements using an ionization chamber. The greatest 
nonlinearity was observed at low MU settings of less than 100 MU with the highest dose per frame. 
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For dosimetric applications, this technique could be avoided by calibrating the EPID with a large 
number of MU. Despite the observed nonlinearity with low MU, EPID performance showed 
comparable responses, within 2%, when operated in cine and integrated acquisition modes. These 
results indicate that for dosimetry applications, no additional corrections are required when the 
EPID operated in cine compared to integrated mode. 
A transit dosimetry method published by Sabet and colleagues in 2014 utilized two-
dimensional (2D) transit EPID images normalized to ionization chamber measurements at the 
depth of dose maximum in water at the EPID plane and included a number of corrections to 
determine the complete 2D field area. The present work expanded on this idea and simplified the 
methodology to determine the complete 2D in-field area by applying a single correction rather 
than several corrections, while maintaining the standard clinical flood field (FF) calibration. The 
calibration method was assessed by comparing transit doses derived from the EPID versus 
MapCHECK for thirty dynamic intensity modulated radiation therapy (dIMRT) fields. The mean 
gamma pass rates in the field area for the examined dIMRT fields were 94% ± 3% (1SD), with a 
maximum and minimum of 99.7% and 86.7%, respectively. The proposed method is less 
complicated than previous measurement approaches. The key advantages of this method are the 
maintenance of the standard clinical FF calibration and the ability to calibrate the whole in-field 
area with a single correction. In addition, the method does not require any kernel application or 
Monte Carlo simulation. This 2D transit dosimetry could be a useful tool for monitoring the dose 
between treatment fractions and for error detection. 
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The feasibility of using EPID-based transit dosimetry and its sensitivity in detecting patient 
variations between treatment fractions were examined using gamma analysis and a structural 
similarity (SSIM) index. The transit EPID dose in the first fraction was considered the reference 
dose and variations in patient position or weight were then introduced in the subsequent fractions. 
The results indicated that the sensitivity of the EPID transit dosimetry methods depended on the 
treatment site, the type of delivery technique, and tissue heterogeneities. The factor that optimized 
the sensitivity of EPID was a reduction in the distance to the agreement criteria. The optimal 
criterion that could detect the most variations was 3%/1mm. With the SSIM index, the EPID can 
detect a 2 mm positional variation and 1 cm of lung variation. The findings in the present study 
indicated a difference between an image-based evaluation method (SSIM) and a typical dose-based 
evaluation method (gamma analysis) using the EPID. Transit measurements during the course of 
patient treatment potentially will aid in the detection of variations that could occur between 
fractions.  
For the second investigation, the current practice of one dimensional measurement at the 
centre of field could not accurately estimate the beam attenuation values for the couch and 
immobilization devices which are a non-homogenous structure. We propose a simple and fast 
method to measure beam attenuation through support devices with either 2D (the attenuated 
image), or 1D (the mean of attenuated image) methods. The proposed method was validated 
against ionization chamber measurements. Beam attenuation through couches and immobilization 
devices was then examined using this method. Beam attenuation measurements using an EPID and 
an ionization chamber agreed to within ± 0.1 to 1.4 % (1 SD). The EPID was found to be able to 
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clearly identify the difference in thickness of the IGRT couch. This study highlights the importance 
of individualized beam attenuation measurement based on the region of couch irradiated. This 
method provides the user with beam attenuation data in either two dimensions or one dimension 
within a few minutes. 
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Chapter 
1 Overview of Radiation Therapy 
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1.1 Cancer and Radiation Therapy 
Cancer is one of the major public health problems. Cancer incidence has increased from 
12.7 million in 2008 to 14.1 million in 2012, as reported in the World Cancer Report 2014, and is 
expected to reach 25 million over the next two decades [1]. This trend is not regional but is 
observed all over the world. Primary methods of cancer treatment are surgery, chemotherapy, and 
radiotherapy. Approximately two-thirds of all cancer patients receive radiotherapy during their 
treatment [2].  
Radiotherapy is the delivery of high-energy radiation to kill cancer cells. The aim of 
radiotherapy is to deliver a high radiation dose to tumor tissue while sparing the surrounding 
normal tissue. Two methods are used to deliver radiation: external beam and internal beam (also 
called brachytherapy). The dose for an external beam is delivered to the patient by an external 
treatment machine called a linear accelerator (linac). The dose for an internal beam is delivered by 
positioning the radioactive source inside or near the region requiring treatment [3].  
External beam therapy uses a standard linac employing high-frequency electromagnetic 
waves to accelerate charged particles (typically electrons) to a high energy. The accelerated 
electrons collide with a heavy metal target to produce x-ray photons in the megavolt (MV) range 
for use in cancer treatment. The typical photon range used is 4–25 MV. Linac is equipped with a 
collimation system which it shaped the photon beams. The collimation system works to obtain 
dose distributions that conform to the tumor volume while sparing neighboring healthy tissue. The 
photon beam is collimated using individual molded blocks and a multileaf collimator (MLC). The 
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individual molded blocks are fixed collimators that consist of two pairs of lead blocks that offer a 
rectangular field ranging in size from 0×0 to 40×40 cm2. The MLC consists of a large number of 
highly absorbing metallic leaves that can be positioned individually to define the field of treatment. 
The photon beam can be delivered to the patient from any angle by rotating the gantry of the linac 
head and moving the treatment couch. The gantry rotates around a central point (the isocenter), 
which is the point of the intersection of the axis of rotation of the gantry and the treatment couch 
and the photon beam [3]. 
The treatment process consists of a number of steps. The first step is called simulation: in 
this step, computed tomography (CT) images are acquired for the patient in a predetermined 
position, where the position of the patient simulates the position that will be used in the treatment 
room. In the simulation room, laser lights are used to match the marks (tattoo) on the skin of the 
patients or on their immobilization devices, so that the simulation geometry can be reproduced in 
the treatment room. Data are then sent to a treatment planning system (TPS) to generate an 
individual treatment plan. This system uses the three-dimensional (3D) imaging information of a 
patient to model the position and shape of both tumor and healthy tissue and to determine the dose 
prescription for the target volumes, as well as the dose limitations for normal tissue. It also 
establishes the beam configuration, including parameters such as photon beam energies, field sizes, 
MLC position, and beam direction. These parameters are used to set up the linac and deliver the 
dose [4].  
The prescribed dose is expressed in units of Gray (Gy), and the dose delivered is related to 
the prescribed dose via a monitor unit (MU), which is the length of time that a beam needs to be  
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delivered for the specified dose [3]. The delivered dose is given every day as a small dose of 
radiation (i.e., in a fractionated manner). Every fraction should be delivered in a reproducible way, 
and the dose delivery in the patient should be as close as possible to the prescribed dose, as 
calculated with the TPS. In the treatment room, the patient is positioned supine or prone on the 
treatment couch in a similar position to that used in the simulation room by using the laser and 
skin marks. In addition, to ensure daily treatment localization, the linac is equipped with an 
imaging system, such as an electronic portal imaging device (EPID) [3, 4]. Figure 1.1 shows an 
example of a standard linac with an attached EPID that is used for verification of patient 
positioning during radiotherapy treatment.  
 
 
Figure 1.1: A Varian linear accelerator (linac) equipped with anelectronic portal imaging device (EPID). 
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1.2 Radiation Therapy Techniques 
The technique of external radiotherapy has been developed significantly over the last two 
decades. Three-dimensional conformal radiation therapy (3DCRT) technique was developed for 
the individualization of radiation treatment planning. Typically, 3DCRT is designed as a set of 
irregularly shaped fields that have uniform intensity across each field. However, 3DCRT has 
shown limited success in achieving difficult treatment geometries. Therefore, the intensity 
modulated radiation therapy (IMRT) technique was developed to enable delivery of a dose 
distribution that conforms more closely to the tumor volume, even for tumors that lie near critical 
structures. The use of IMRT has rapidly increased worldwide as a clinical routine. The MLC 
shapes the dose by producing several small and irregular fields during the treatment. As a result, 
each field in the IMRT approach may contain a complex dose distribution with significant dose 
gradients [5, 6]. The treatment may be delivered either dynamically (dMLC) or using static 
segments (sMLC). For the dMLC technique, or sliding window, the MLC leaves move while the 
beam is on to create the desired dose distribution. By contrast, the sMLC technique uses the MLC 
to create multiple small and irregular segments for each field, with each segment delivered using 
a step and shoot technique [7].  
A more advanced radiotherapy technique is volumetric modulated arc therapy (VMAT), in 
which the beam is delivered continuously with a changing dose rate and a rotating gantry. The 
increasing development of image technology has permitted greater optimization of IMRT or 
VMAT by a combination of IMRT or VMAT techniques and an image guided radiotherapy 
technique (IGRT). The aim of this combination is to guide the tumor movement during treatment. 
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Different real-time imaging systems, such as the EPID, fluoroscopy, and cone beam computed 
tomography (CBCT), can be used with IGRT to determine the position of the tumor before or 
during treatment [7, 8]. A relatively new technique is stereotactic ablative radiotherapy (SABR), 
which utilizes high doses of radiation in a few fractions.  
1.3 Verification in Radiotherapy  
The purpose of radiotherapy is to deliver a radiation dose to the patient safely, accurately, 
and efficiently. Radiotherapy involves many steps and individuals in the planning and delivery of 
the treatment. Such procedures can have opportunities for errors occurring in any step; for 
example, data errors (input) and machine errors (field size, gantry angle, etc.) [9]. Therefore, a 
verification process that reduces the likelihood of accidents and errors is required to ensure that 
patients will receive the prescribed treatment correctly. Comprehensive quality assurance (QA) 
programs have been introduced, and these are obligatory in current clinical practice.  
A QA program should aim to verify the correct functioning of all components in the 
radiotherapy chain, including the treatment planning and treatment delivery system [10, 11]. With 
the increasing complexity of delivery techniques and the reported occurrence of errors in 
radiotherapy, patient-specific treatment verification (pre-treatment verification) is also required to 
validate individual patient treatment. Pre-treatment verification continues to be a part of current 
guidelines by international organizations [7]. In addition to pre-treatment verification, the 
measurement of the radiation dose received by the patient during treatment (i.e., in vivo 
verification) is highly recommended by many national and international organizations as a safety 
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tool to avoid major errors. In vivo verification is not widely or routinely applied to individual 
patients except during special treatments [12-15].  
Pre-treatment verification traces possible errors in both treatment planning and the delivery 
process; however, several studies have reported that the pre-treatment approach is limited to 
certain types of error. By contrast, in vivo verification can detect more errors because a number of 
potential events relating to technical or patient issues can occur between the planning and delivery 
time. A Netherlands cancer center that reported the results of verification for over 4,337 patients 
found that seventeen serious errors were detected, and nine of these errors would not have been 
detected with pre-treatment verification [16]. In addition, a voluntary in-house incident system 
reported that the pre-treatment dose verification of 2,599 incidents could detect only about 6% of 
the examined incident errors, while in vivo dose verification could detect 74% of the variations in 
the first fraction and 20% between fractions [17].  
The errors that can occur between treatment fractions are changes in patient anatomy and 
position. In clinical practice, these types of variations are verified by image modality; for example, 
by planar kilovoltage radiographs and CBCT. However, these modalities have limitations in 
regards to providing extra doses to patients and no dosimetric information can be interpreted from 
the images. In addition, a planar kilovoltage radiograph cannot identify internal changes in soft 
tissue anatomy [18]. Moreover, a patient position shift could happen after the image guidance 
procedure and before (or during) treatment [19]. A published survey of physicians that routinely 
used this modality indicated that the physicians used image-guided radiation therapy only rarely 
(28.9% of their patients) or infrequently (33.1% of their patients) [20].  
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1.4 Detectors Used for Dose Verification  
Dose verification is the most important aspect of the verification procedure, either before 
or during treatment. In present-day clinical practice, a variety of dosimetry systems can be used 
for dose verification before treatment. The traditional methods of dose verification use one 
dimensional (1D) systems, typically an ionization chamber. Dosimetry systems using two 
dimensional (2D) or three dimensional (3D) techniques have replaced 1D dosimeters in a number 
of centers. These include 2D arrays of ionization chambers or diodes [21], such as Mapcheck (Sun 
Nuclear, Melbourne, USA), and 3D array detectors arranged in helical or crossed arrays, such as 
ArcCHECK (Sun Nuclear Melbourne, USA) [22].  
The current detectors utilized for dose verification during treatment are mainly limited by 
the fact that one point cannot provide enough information to validate the variation in fluence across 
each field. In addition, these detectors require time to set up, such as diodes, thermoluminescence 
detectors and metal oxide field effect transistors. The currently available 2D dosimeters include 
radio-chromic film, EPID, and a relatively new transmission detector mounted in the head of the 
linac. The main characteristics and limitations for these detectors is shown in Table 1.1. Compared 
to radio-chromic film, the EPID is superior because it requires a little time to set up. In addition, 
unlike a transmission detector mounted in the head of a linac, the EPID can acquire the exit dose 
from the patient. 
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Table 1.1: The characteristicsof 2D detectors used for in vivo verification. 
Dosimetry Description  Advantages Disadvantages Example of Commercial Products 
Radio-chromic 
film  
 
2D sheet detector Permanent record, self-
processing and high resolution 
e.g., Microtek ScanMaker i900 
(Microtek International Inc., 
Taiwan) provides a 3200 × 6400 
dpi optical resolution [23] 
Single use; scanner and software 
required for analysis. Delayed 
readout: several hours to fully 
develop [24, 25] 
Gafchromic, EBT3 
(Ashland Inc., USA) 
 
EPID A portal imaging 
device utilizing an 
amorphous silicon 
detection system 
attached to a linac 
[21] 
Readily available in a standard 
linac, minimal setup time, high 
resolution, large imaging area, 
fast acquisition system, potential 
for 3D and 4D reconstructed 
dose, potential for real-time 
readout [26, 27] 
Originally designed for imaging, 
it is not water equivalent and 
correction is required for dose 
conversion; commercial solutions 
are just emerging but are not 
mature enough for widespread 
adoption [28-32] 
Dosimetry Check (Math 
Resolution, LCC, Columbia) [33] 
Transmission 
detector mounted 
in the head of the 
linac 
2D arrays of 
ionization chambers 
or diodes positioned 
upstream from the 
patient [28] 
 
 
Design for QA during treatment 
to monitor photon fluence, 
energy, beam shape, and gantry 
position; no user interaction 
during treatment; real time 
readout; a new version design for 
3D reconstruction of doses [28, 
34] 
Low resolution (5 mm - 10 mm); 
attenuate the delivered beam, 
which could increase the surface 
dose and scattered dose to the 
patient; current versions cannot 
evaluate the exit dose from 
patient; these devices are still rare 
in clinical practice [28, 34-36] 
(Dolphin, IBA Dosimetry) [34],  
QM (iQRT, Germany) [35]  
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2.1 EPID Structure and System 
The EPID is used to verify the patient’s position during a treatment fraction. It measures 
the x-ray intensity transmitted through the patient, and the radiation signal is converted 
electronically into a 2D digital image (megavoltage image). Position verification is typically 
performed by  comparison of a portal image acquired during a treatment fraction with a reference 
image acquired prior to the initiation of the treatment course. Different EPID technologies have 
been proposed since the 1950s, but only a few have been widely adopted in the clinical setting. 
These include the scanning liquid-filled ionization chamber EPID, the camera-based EPID, and 
the active matrix flat-panel imager EPID with amorphous silicon (a-Si) array and amorphous 
selenium (a-Se) array [37, 38].  
An EPID-based flat-panel consists of four subsystems [38, 39], as illustrated in Figure 2.1. 
The four subsystems are the following: 
1. A large array, pixelated array: the array consists of a 1 mm thick glass substrate. 
Each pixel has an electronic circuit capable of storing the resulting charge. The 
pixels are ordered on a two-dimensional grid. Typically, hydrogenated amorphous 
silicon (a-Si: H) is constructed into a thin-film transistor for use in the EPID. A 
thin-film switch in each pixel has three electrical connections: the gate, the source, 
and the drain. The source is the capacitor that stores the electrical signals resulting 
from the interaction of the radiation with the X-ray converter. The drain is 
connected to the data line (vertical wire) and the gate is connected to the gate line 
(horizontal wire). The switch is controlled by changing the voltage of the gate lines. 
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Each gate line is joined to all the switches of a specific row. At an irradiation time, 
the electrical signals resulting from interaction of the radiation with the X-ray 
converter are stored in the capacitive element of each pixel, while the switches are 
maintained in a non-conducting state. The image is read by making the switches 
conducting, and one row of pixels at a time are read out. The charges are then 
transported to the external electronics via data lines. Each data line is linked to all 
pixels in a particular column. 
2. An overlying X-ray converter: the incident high energy X-rays and electrons 
interact and are converted to charges that are stored. An overlying X-ray converter 
is integrated into the capacitive element of each pixel. Two techniques, direct and 
indirect, are available for this conversion. The differences between the techniques 
are classified depending on how the charges are produced and stored. For the direct 
technique, the X-ray converter consists of a metal plate and a photoconductor. The 
electron–hole pairs are generated in the photoconductor then stored in the capacitor, 
where a photoconductor is combined electrically with a separate capacitor built into 
each pixel. For the indirect technique, the converter consists of a metal plate and a 
scintillator (phosphor screen) which converts the incident radiation into light 
photons. This light interacts in photosensor (photodiodes) and produces electron–
hole pairs. The structure of the photosensor also forms the capacitive element in 
each pixel, where this signal is stored until readout. 
3. An electronic acquisition system: manages the operation of pixels and extracts and 
processes signals from the pixels.  
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4. A host computer and information system: collects and processes digital data from 
the acquisition system and then displays and archives the resulting digital image.  
 
Figure 2.1: Diagram of the subsystem components of a flat panel imager [38]. 
Currently, the main linear accelerator manufacturers incorporate a-Si EPID (indirect 
detection based photo diode array) for routine clinical applications because of its superior image 
quality. In this thesis, the use of the EPID refers to an a-Si EPID type unless otherwise specified. 
The active matrix area and pixel resolution of an a-Si EPID varies. The typical active area of an a-
Si EPID mounted to a Varian linac (as used in this thesis) is 40×30 cm2 with a pixel pitch of 0.39 
mm2 and 0.78 mm2 for the aS1000 and aS500, respectively [40, 41]. Varian has recently released 
the aS1200, which has a large matrix area of 40×40 cm2 with a pixel pitch of 0.336 mm and a 
higher resolution than previous instruments [42].  
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2.2 EPID Applications 
The advantages of the EPID, such as the incorporation of currently available linacs, high 
resolution, and digital format, have encouraged researchers to explore the possibility of using the 
EPID for other applications in radiotherapy treatment.  
2.2.1 Quality Assurance 
EPID is used for daily checks of the linac output and to provide daily monitoring of beam 
profile parameters, such as flatness, symmetry, and field size [43, 44]. In addition, EPID is used 
for IMRT QA particularly to verify MLC position [45-50] , and for VMAT QA mainly for 
verification of the gantry angle [51-55].  
2.2.2 Dose Verification 
The EPID images (megavoltage images) acquired during radiation delivery do not only 
have anatomical information about the patient; they also provide 2D information about the dose 
received by the patient. Therefore, the implementation of the EPID for dose verification in clinical 
practice has received great attention. Before reviewing the literature about EPID dosimetry, 
common terminology associated with the EPID is described below:  
Two approaches are used with the EPID for dose measurement. The EPID is calibrated to 
convert the grey scale pixel value of an EPID image to a dose value, which is then typically 
compared to the TPS dose calculation. Another common approach is to predict the grey scale pixel 
value using TPS or Monte Carlo (MC) simulation, and then to compare this to the measured EPID 
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response. In addition to classifying EPID by the calibration method, EPID dosimetry can be 
classified based on where the doses are compared. This could be at the patient level or at the EPID 
level, as shown in Figure 2.2.  
Another classification, referred to as non-transit dosimetry or transit dosimetry based on 
the presence or absence of an attenuator object, is shown in Figure 2.3. In non-transit dosimetry, 
the EPID captures the delivered radiation through the air without an attenuator between the source 
and the EPID detector. In a transit dosimetry, the EPID captures the delivered radiation that transits 
through the attenuator (a phantom or the patient). Since no attenuator can be present for non-transit 
dosimetry, the technique is limited only to pre-treatment verification. Conversely, transit 
dosimetry can be used for both pre-treatment and actual treatment verification [31]. In the research 
described in this thesis, we use transit dosimetry for measurements conducted during treatment.  
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Figure 2.2: EPID dosimetry classified based on the position of the dose comparison. 
 
Figure 2.3: EPID dosimetry classified based on the absence or presence of an attenuator. 
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2.2.2.1 Dosimetric Characteristics of EPID  
Two modes of image acquisition are available when using an a-Si EPID. A well-established 
mode for dosimetric application is integrated acquisition mode. In this mode, the EPID captures a 
single image consisting of the average of many image frames acquired during radiation delivery; 
a frame is a single scan of all the EPID rows. An alternative mode is continuous acquisition mode, 
which is also termed cine mode. With this mode, the EPID captures a sequence of multiple images 
during radiation delivery. The advantage of this mode is that EPID dose data are captured as a 
function of time during delivery radiation. The dosimetric characteristics of an EPID operated in 
the integrated mode have been studied in detail, whereas only a few reports exist for the dosimetric 
characteristics of an EPID operated in cine mode [56, 57]. In this section, the literature of the 
dosimetric characteristics of an EPID operated in the integrated mode is presented. The literature 
of the cine mode is presented in Chapter Three.  
The linearity and reproducibility of an EPID signal with respect to the dose delivered has 
been confirmed in a number of studies. The linearity of the EPID signal to the delivered dose for 
eleven EPID panels was reported to be within 2% for 20 MU and within 1% for 50 MU and higher 
[58]. The linear response of an EPID signal to the delivered dose was within 2% for the primary 
radiation deliveries and within 10% for the transmitted radiation deliveries [59].  Greer et al. [40] 
also reported a linear response for the EPID signal with MLC speeds up to 2.5 cm.s-1. Linearity 
with the dose rate was found to be within ± 2 % when the nominal dose rate varied from 100 to 
600 MU/min [58, 60], and within ± 0.2 % when the nominal dose rate was varied by changing the 
source to detector distance (SDD) to below the isocenter [40]. The EPID signal uniformity across 
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the eleven detector panels was within 95%, which met the acceptable limit for radiation field 
uniformity [58]. The overall reproducibility was reported to be within ± 2% for static and dynamic 
fields [58, 61]. The short-term reproducibility of the EPID signal, images were acquired in same 
day, was less than ± 0.14%  [58].  The long-term reproducibility of the EPID signal was about ± 
0.21% over a period of six months [58], and about ± 0.5% over a period of up to 23 months [62]. 
A degree of nonlinearity in the response of the EPID signal with delivered dose was 
observed when early generation of image acquisition system was used due to dead time occurring 
every 64 images [40]. For current acquisition systems, this issue has been resolved [58]. Moreover, 
the EPID signal exhibits a nonlinear response when a low number of MU are delivered due to the 
trapped charge in the photodiodes (a ghosting effect). A signal response of around 4 to 10 relatives 
to the signal response of 1000 MU was reported. The ghosting effect is more obvious with 
decreasing time intervals between two exposures [63-65]. However, when the EPID is used with 
IMRT delivery, the nonlinearity of the EPID is negligible because the EPID images with a common 
IMRT treatment integrate a small MU for each segment. In this case, the ghosting effect only needs 
to be considered if an image with a small MU for each segment is used [30]. 
2.2.2.2 Limitations of EPID Dosimetric Characteristics 
The EPID signal has good linearity and reproducibility, but the dose deposition behavior 
in the EPID is not identical to that dose in water. Differences between EPID and the well-
established detector in an ionization chamber has been reported. This difference arises because the 
EPID was originally designed for imaging applications, not for dosimetry applications. The main 
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limitations are the conventional calibration of the EPID images and the presence of a phosphor 
layer in the structure of the EPID. In addition, the Varian EPID supporting arm produces a non-
uniform backscatter. The solutions offered to address these problems will be presented in Chapter 
Four.  
2.2.2.2.1 Conventional Calibration of EPID Images 
Clinically, to optimize the image quality, the EPID should be calibrated prior to image 
acquisition. The purpose of the calibration is to remove background noise and the variations in 
individual pixel responses. The conventional calibration procedure includes two steps: one is to 
acquire an image without radiation: a dark field (DF) image to remove the noise information. The 
other is to acquire an image with an open radiation field: a flood field (FF) image to correct the 
variations in individual pixel responses. The raw EPID image is multiplied by a DF image, 
followed by division of the FF image.  
Ideally, the FF image should be acquired using a uniformly delivered field. In a clinical 
linac, the existence of a flattening filter, which is designed to produce a flat profile in a depth of 
10 cm in water, makes the delivery field non-flat (horn effect) at the shallow depth where the FF 
image is acquired. Both the raw EPID image and the FF image have this horn effect. As a result 
of the division process, the calibrated EPID image would not be representative of the horn effect. 
The removal of the horn effect from the EPID image has no impact on the imaging application, 
but it does have an impact on the dosimetry application due to loss of some dose information from 
the delivered field [66]. Greer [67] showed that the difference between an ideal FF image and a 
clinical FF image was as much as 12.2%. 
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2.2.2.2.2 Presence of a Phosphor Layer 
A main challenge to the use of the EPID in dosimetry applications is the presence of the 
phosphor layer (gadolinium oxysulfide) as a component in the EPID structure. The high atomic 
number of the phosphor layer causes an over-response of the EPID to low energy photons. This is 
due to the mass energy absorption coefficient of the phosphor layer, which increases significantly 
below 1 MeV [68] . The hypersensitivity of the EPID to low energy photons leads to a number of 
problems when the EPID is applied for dosimetry purposes. In particular, the typical radiotherapy 
beam has a significant component of the beam less than 1 MeV. This makes the EPID response 
dependent on the energy spectrum, field size, phantom thickness, and MLC transmission.  
The typical clinical beam has variations in energy spectra as a result of the flattening filter, 
which increases the low energy photon component of beam with increasing distance from the 
central axis [69, 70]. As a consequence, the EPID response at off-axis positions is higher than the 
response at central axis positions; this over-response at the off-axis distance is not identical to the 
dose in the water response [67, 71]. The EPID response between the on  and off-axis beam for the 
open beam was reported as 2% [67], and the maximum variation in the EPID response was 28% 
using MC simulation [72]. The EPID off-axis differential response is higher at 6 MV than at 18 
MV. The EPID over-response at a 20 cm off axis compared to the center axis was 0.5% and 0.3% 
for 6 and 18 MV, respectively [67]. 
Hypersensitivity of the EPID to low energy photons cause also field size dependence [40, 
73]. This occurs because radiation scattering increases with increasing field size, and the scatter 
has a low energy component. The field size dependence of the EPID has been compared to the 
25 
 
ionization chamber dependence by Greer et al.[40], who reported that the field size dependent 
response of the EPID was up to 5% of the ion-chamber measurement. Van et al.[61] reported a 
higher value, with a field size dependence of EPID of 9% of the ionization chamber measurement 
in water at the center of the beam. Nijsten et al. [74] observed a decreased EPID response with the 
field size, and the maximum under-response was 7.7% for a 3×3 cm2 field. By contrast, with an 
increased field size, the maximum over-response was 2.1% for a 24.2×24.2 cm2 field. Gustafsson 
et al. [75]  identified the reason for the EPID field size dependence by analyzing the impact of 
each layer on the EPID. For a photon energy of 6 MV, the phosphor layer has a high effect on the 
EPID field size response. For a photon energy of 18 MV, head scatter has a significant effect on 
the EPID response.  
The MLC changes the properties of the delivered radiation beam [76]. One of the effects 
of the MLC is hardening (filtering) the delivered radiation beam; that is, the removal of the low 
energy photon component of the beam. Given the increase in the response of the EPID to low 
energy photons, the removal of these photons reduces the response of the EPID [77]. The ratio of 
the EPID response at the central axis for an open radiation beam to the MLC beam for delivering 
a field size of 10×10 cm2  was reported to be 0.78 by experimental methods [77], 0.77 using MC 
simulation [78] and 0.79 using TPS [79].  
As with MLC, the presence of a patient filters the delivered radiation beam, which leads to 
increased photon mean energy. The maximum difference in the EPID over-response between an 
open and a filtered beam can be 10% at the center of the field calculated using MC [68, 80]. The 
difference between the EPID and the ionization chamber response at the center of the field, when 
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the beam was filtered, it was measured at about 6% [73]. The presence of the patient not only 
affects the center axis, but it also reduces the hypersensitivity of the EPID at the off-axis distance; 
a reduction of 0.5% was reported between the off-axis distance with and without an existing 
phantom [67].  
In addition to the hypersensitivity of the EPID caused by the phosphor layer, the scatter of 
photons in the phosphor layer of the detector causes blurring of the resulting image, a phenomenon 
known as the glare effect. The glare effect was a considerable drawback for the previous generation 
of EPIDs (e.g., camera-based EPIDs) because, along with optical diffusion in the screen layer, 
these EPIDs also had multiple optical reflections occurring between the screen and mirror. These 
reflections contributed significantly to the glare effect. Studies on the current clinical EPIDs have 
shown that the glare effect is negligible in most cases [81, 82]. 
2.2.2.2.3 Backscatter from the Supporting Arm 
A particular challenge to the use of the Varian EPID is a non-uniform backscatter from the 
supporting arm. The Varian EPID panel is attached to a linac via a supporting arm to produce the 
movement of the EPID panel into the required position. The older design of the supporting arm 
was called the retractable arm (R-arm) and the current design is called the exact arm (E-arm). 
These supporting arms have a number of metallic components that position under the sensitive 
area of the imager panel. These components produce backscattered radiation, which increases the 
response of the EPID [83-85]. The increase in the EPID response due to backscatter was reported 
at around 5% for the R-arm [84] , and at between 6.5%  for the E-arm [86].  
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2.2.2.3 Dose Verification before Treatment 
The EPID has been extensively studied in pre-treatment verification. A number of studies 
on proposed approaches and clinical experience have been published, and a number of commercial 
solutions have been realized. In addition, the ability of the EPID to detect errors occurring before 
patient treatment was quantified, errors such as increase or decrease the number of monitor units, 
widen the MLC banks, and change the collimator or gantry angle [17, 26, 87-94].  
2.2.2.3.1 Proposed approaches 
A detailed literature review of pre-treatment verification using the EPID is available in the 
paper by Van et al. [31]. Briefly, dose verification was performed at the level of the EPID [61, 80, 
95-99] or at the level of the patient [71, 78, 100-111] .  
2.2.2.3.2 Commercial Solutions 
2.2.2.3.2.1 Portal Dosimetry  
The Portal Dosimetry (Varian Medical System, Palo Alto, California) system is based on 
the methods described by Van Esch et al. [61] and was developed for non-transmission pre-
treatment verification. A single pencil beam dose calculation algorithm is applied on TPS to predict 
portal dose images for the planned fluence of the delivered beam. The predicted portal dose image 
is then compared to the measured EPID images using an arbitrary unit, termed the calibrated unit, 
at the level of the EPID. The planned fluence interaction with the EPID is predicted by separating 
the predicted dose calculation into phantom scatter and collimator scatter. Phantom scatter is taken 
into account in the planned fluence by being convolved with the single pencil beam kernel. The 
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collimator scatter factor can be determined from the output factor measurements and the calculated 
scatter of the phantom. However, the prediction algorithm in the Portal Dosimetry system has a 
limitation with regard to its ability to account for the effect of MLC transmission in the off-axis 
region. This factor yields differences between the predicted and measured portal dose images of 
up to 7.1% at 17.5 cm from the center of the detector for 6 MV [112].  
2.2.2.3.2.2 EPIDose  
EPIDose (Sun Nuclear Corporation, Melbourne, Florida) is a suite of commercial software 
tools that can be used with any vendor’s accelerators. The EPIDose method, described by Nelms 
et al.[32], is similar to portal dosimetry as it is employed for pre-treatment verification; however, 
this tool applies a dose conversion algorithm to convert EPID images to a water equivalent dose, 
and the comparison between the EPID dose images and TPS dose is conducted at the patient level. 
To achieve this, the raw EPID image is projected geometrically to the patient level. A correction 
map is applied on the EPID image, which accounts for the EPID response for the field size of each 
segment and the region blocked by MLC leaves. The results are convolved with a “Dose 
Redistribution Kernel” to simulate the dose distributions in water. A 2D wide field calibration map 
is applied to convert the individual pixel values of the image to absolute dose points. All 
measurements for parameters required for EPIDose commission are conducted using MapCHECK 
dosimetry (Sun Nuclear, Melbourne, FL). 
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2.2.2.3.2.3 Epiqa  
Epiqa (Bratislava, Slovakia) is software used for pre-treatment verification that has been 
developed based on the work of Nicolini et al.[59]. The Epiqa system converts EPID images to an 
absolute dose map at a depth of a maximum dose in water and is then compared to a dose calculated 
by TPS. With this model, the total dose for a given field is calculated as the sum of two 
components: the primary dose (field under the jaw) and the transmitted dose (under the MLC). 
The scatter dose is not accounted for separately because it is included in both the primary and 
transmitted doses. A given modulated field consisting of a series of small subfields is shaped by a 
fixed setting of the jaws and a variable MLC shape. The equivalent window width field is a new 
concept that has been employed to define an effective field size for each segment; it is derived 
from information stored in the MLC file that accounts for leaf position and weights. 
2.2.2.4 Dose Verification during Treatment 
For transmission applications, which could refer to in vivo verification, a number of 
proposed approaches are available; however, only a limited number of these approaches have been 
clinically implemented. This is mainly because of the complexity of reproducing these methods 
and because commercial solutions have only been released recently. In addition, the available data 
are limited regarding the sensitivity of the EPID to detect inter-fraction patient variations; specific 
literature regarding the sensitivity of the EPID is reviewed in Chapter Five. In this section, the 
approaches for dose verification are presented for EPIDs, either proposed or commercialized, and 
highlighted if used in clinical practice. 
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2.2.2.4.1 Proposed Approaches 
2.2.2.4.1.1 EPID based Monte Carlo Simulation Approach 
An MC approach was used either fully or partially with other resources and algorithms, 
and an MC approach was used either at the patient level or the EPID level. Cufflin et al. [113] and 
Gardner et al. [114] used a full MC approach to model the linac and the EPID. After modeling the 
machine, the application of a kernel via a convolution and deconvolution process was utilized to 
predict the transit EPID image at the EPID level. The kernels described the scatter or dose 
deposition properties in the EPID or phantom/patient. Yeo et al. [115] and Jung et al. [116] 
developed a full MC approach that pre-calculated the EPID transit dose and reconstructed the dose 
within the patient. Recently, the same group studied the feasibility of 4D reconstructed dose 
verification based on an EPID with a cine acquisition mode [117]. 
Groups in Newcastle from Australia and Canada used partially employment of  MC 
simulation at the EPID level [118],  and extended the energy fluency prediction model used for 
pre-treatment verification by Chytyk and McCurdy [96]. In this approach, the primary fluence 
attenuation through the patient is taken into account using CT data and the inverse square law. MC 
simulation was used to model the details of the linac and a series of scatter kernels accounted for 
patient scatter and the EPID energy response. The predictions were presented in absolute grayscale 
units. This approach was further developed in two ways. First, Fuangrod et al. [119-122] developed 
a real-time dose verification system based on MATLAB/Simulink software at the level of the 
EPID. Second, a model to reconstruct the dose at the level of patient was used for SBRT–VMAT 
delivery [123, 124]. 
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Even though the accuracy of EPID dosimetry was reported by using MC simulation, the 
routine application of MC based EPID dosimetry may not be currently possible because it is 
computationally intensive, especially in clinical departments with a large number of linacs and 
limited resources. 
2.2.2.4.1.2 EPID based Measurement Approach 
2.2.2.4.1.2.1 Measurement Approach with Kernel 
Instead of using MC simulation with a model linac and EPID to calculate the required 
kernel, measurement approaches can be employed to derive the required kernel. For example, 
Chen et al. [125] converted the EPID response into the equivalent water dose deposited at a depth 
of 1.5 cm at the EPID level using convolution models. This was achieved by conducting a series 
of measurements for different field sizes to derive the EPID and water kernels. A tabulated 
conversion function, which accounted for the EPID energy spectra dependence, was obtained by 
measurement at various off-axis positions with increasing attenuator thickness in beam. A similar 
convolution approach was proposed by Nijsten et al.[74]. Instead of using a tabulated conversion 
function to account for the EPID energy spectra dependence, the applied correction consisted of a 
multiplication of two individual corrections. One measured the ratio of the transmission of a beam 
through the phantom/patient while the other accounted for the patient scattered dose under 
different field sizes.  
Recently, Peca & Brown [126] adapted the model developed by an Italian group [127]; this 
will be described in more detail in the following section. Peca & Brown’s correlation functions 
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were used to reconstruct the dose at the patient level. The variability of these correlation functions 
at the off-axis positions was taken into account by dividing the EPID image by the TPS computed 
2D dose at the mid-plane of water, and a 2D map of radiological path length was derived from the 
CT data to account for tissue inhomogeneity.  
Overall, the measurment-based EPID dosimetry approaches using kernel are less 
computationally intensive when compared to MC simulation, but the use of kernels still requires 
appropriate expertise and software for mathematical modelling. Therefore, these approaches 
remain mostly contained within the research department where the model was developed.  
2.2.2.4.1.2.2 Measurement Approach without Kernel 
EPID based measurement dosimetry without the application of a kernel may be the most 
practical approach for clinical implementation, as it does not required expertise in computer skills 
or special software. However, at present, only two approaches have been proposed to obtain EPID 
transit dosimetry based on measurement only. A group in Italy [127] has applied a method that 
provides one-point dose measurement, at the isocenter (patient level). The dose at the isocenter 
point was calculated based on the correlation function between the EPID transit image positioned 
behind water phantoms and the dose measured by an ionization chamber positioned at that point. 
The agreement between the isocenter reconstructed dose and the TPS calculated dose was within 
5%. This approach was applied in the clinical setting in a number of reports for 3DCRD [127-129] 
, IMRT [130] , and VMAT [131, 132] deliveries. To reduce the time required for implementation 
of each linac, a generalized EPID calibration was performed for the Varian [133], and Elekta [134] 
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EPIDs. However, the main disadvantage of this approach is that it provides the dose information 
for one point. A group from Newcastle developed a new approach in 2014 [135] that included a 
set of correction matrixes to model the transit EPID dose at the EPID level. A correction was 
extracted by comparing the EPID response and ionization chamber response under different field 
sizes and phantom thickness. 
2.2.2.4.2 Commercial Solutions 
2.2.2.4.2.1 Dosimetry Check  
Dosimetry Check (Math Resolution, LCC, Columbia) is the first software released for use 
in pre-treatment and in vivo verification for both IMRT and VMAT plans. Based on the work of 
Renner et al. [136, 137], it works with any vendors. This tool reconstructs the dose on patient data 
and compares it to the TPS dose. This tool has established a relationship between the monitor unit 
and the grey level of the EPID images, which represents the number of monitor units that produce 
the same grey level at the center of the reference field. Then, the EPID images are deconvolved 
with the kernel. This step is done in the frequency domain, and the kernel is determined through a 
fitting process between the reconstructed dose and the dose measured in water. Therefore, a series 
of integrated images is acquired for a number of field sizes. A number of field sizes at different 
depths with different source to surface distances are also measured with an ionization chamber. 
This fluence is used as input for the Dosimetry Check software. A pencil beam calculation 
algorithm is employed to reconstruct the dose on the CT images that represent the patient 
geometry. The reconstruction dose is compared to the dose from the TPS. However, for a 
heterogeneous region, the difference between the Dosimetry Check system and the TPS was as 
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high as 15%. This is because the Dosimetry Check does not account for the couch attenuation in 
the case of transmission measurement [138].  In clinical practice, the Dosimetry Check is gradually 
being utilized. 
2.2.2.4.2.2 EPIgray  
EPIgray (Dosisoft, Cachan, France) is applied for in vivo dosimetry. It was developed 
according to the method described by Francois et al. [139]. However, this solution only provides 
dose information at one point. The method by which this software proceeds depends on a back-
projected EPID signal to the patient level. With this solution, the EPID response is converted to a 
dose at the maximum depth in water by establishing a conversion factor. It represents the ratio 
between the transit dose measured with an ionization chamber in a water equivalent phantom at 
maximum depth dose without a patient and the signal measured with the EPID for a given 
attenuator thickness and field size. The conversion factor is measured for a range of square fields 
and absorber thicknesses. The transit tissue maximum ratio is calculated to account for the air gap 
for the scatter between the patient and detector; these measurements are undertaken with an 
ionization chamber. The inverse square law is applied to determine the dose at the point of interest.  
2.2.2.4.2.3 iViewDose  
The iViewDose software (Elekta AB, Stockholm, Sweden) was developed by the 
Netherlands Cancer Institute group. Major clinical contribution to EPID transmission applications 
come from this group. They  extended the back projection algorithm, which is widely used for pre-
treatment verification, to in vivo verification [140]. The results revealed that a 3D EPID dosimetry 
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method could be used for in vivo verification of IMRT plans as an accurate and fast tool. This 
method is based on the reconstruction of two-dimensional dose distributions at the level of the 
patient from EPID images [141]. This approach is accomplished through a number of steps. First, 
a dose response relationship is created to convert the detected EPID pixel value to a dose value at 
the level of the EPID, using ionization chamber measurements. The EPID is calibrated to the 
ionization chamber using dose profile measurements instead of the central axis to represent 
information in the off-axis and penumbra regions. Converting the dose from the EPID level to a 
dose at specific points at the phantom level is completed by definition of the scatter component. 
The patient contours from the planning CT scan are used to reconstruct the dose. In order to obtain 
the transmission ratio, an open field is measured by the EPID with and without the patient. 
Pecharromán-Gallego et al. [142] replaced the transmission ratio obtained from the EPID image 
with one obtained from the path length determined from the CT images. This reduced the extra 
dose delivered to the patient to obtain transmission ratio. Wendling et al. [143] modified the back-
projection algorithm to improve its accuracy for tissue with significant inhomogeneity, specifically 
lung cancer. Olaciregui-Ruiz et al.[144] automated the procedure of in vivo dose verifications so 
that it was available within a few minutes after delivery. Hanson et al.[145] reduced the required 
commissioning time dose calculation implemented on a standard commercial MV imaging 
platform. Rozendaal et al.[146] showed the advantage of including daily CBCT images in EPID 
dose reconstructions. Overall, the accuracy of this approach and the ability of methods to detect 
serious errors has been confirmed in a number of studies [147-149]. Although this approach 
reported high accuracy results and the ability to detect errors, this approach was only applied in 
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that center due to the complexity of reproducing the approach and the commercial software was 
only realized in 2017. 
2.2.2.4.2.4 PerFRACTION  
PerFRACTION (Sun Nuclear, FL, USA) software was also realized in 2016–2017. The 
transmission EPID image captured during the treatment session is compared to the baseline image 
(the first fraction). However, no dose information can be extracted [150]. 
An overall summary of all the commercial solutions for EPID dosimetry is illustrated in 
Table 2.1. Although commercial solutions have been presented and are continuing to emerge but 
are not mature enough for widespread adoption, and or, prohibitive in cost. 
2.2.3 Beam Attenuation Measurements 
Vieira et al. [151] demonstrated the efficiency of the EPID (based-camera) as a tool to 
measure beam attenuation in 2D through different components of the treatment couch and 
immobilization devices. However, the proposed approach limits on the using of the entire 2D 
attenuated image. A detailed literature review for measuring beam attenuation through couch is 
available in the Chapter Six. 
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Table 2.1: A comparison of the main characteristic features for each EPID commercial solution. 
 Portal 
Dosimetry 
EPIDose 
 
Epiqa 
 
Dosimetry Check 
 
EPIgray 
 
iViewDose PerFRACTION 
Verification type pre-treatment pre-treatment pre-treatment pre-treatment & 
in vivo 
pre-treatment 
& in vivo 
pre-treatment 
& in vivo 
in vivo 
Level of 
verification 
2D 
at EPID level 
2D 
at patient level 
2D 
at patient level 
3D
at patient level 
1D  
at patient level 
3D
at patient level 
2D  
at EPID level  
Water -
equivalent dose 
No Yes Yes Yes Yes Yes No 
Reference 
reported the 
accuracy of 
system 
[152, 153] 
 
[26, 154] 
 
[153, 155, 156] 
 
[138, 157-159] 
 
[160, 161] 
 
[162] [150] 
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2.3 Thesis Aim 
The aim of this thesis is to extend the application of the EPID to (i) use it in transit 
dosimetry and (ii) as a tool to measure beam attenuation through the couch and immobilization 
devices with the overall goal of providing a simple procedure that would use minimal resources. 
Each chapter in this thesis will report results from stand-alone experiments, and will include an 
introduction, methods, results, discussion, and conclusion. 
For the first area: 
1. Dosimetric characteristics for cine acquisition mode will be examined. 
2. An EPID based measurement approach for transit dosimetry applications will be 
developed. 
3. The feasibility and sensitivity of using EPID transit dosimetry to monitor inter-
fraction patient variations will be investigated. 
For the second area:  
1. A simple approach will be developed to characterize the attenuation beam through the 
couch and immobilization devices in different geometries.  
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Chapter 
3 The Influence of Acquisition Mode on the 
Dosimetric Performance of an a-Si EPID 
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3.1 Introduction 
The primary purpose of EPID is patient localization during radiotherapy treatment. The 
EPID has a number of important features for dosimetry applications; its integration with a linear 
accelerator, high resolution, fast image acquisition and large imaging area [31]. The latest 
generation of EPID is an a-Si consisting of phosphor scintillator and photodiode detectors. A well-
established acquisition mode for dosimetric application is the integrated mode. An alternative 
acquisition mode is the cine mode, which is attractive for the assessment of dynamic procedures. 
In cine acquisition mode, a sequence of multiple images are captured during radiation delivery 
instead of a single integrated image [30]. Since cine mode is synchronized to beam pulses, the 
frame acquisition rate depends on dose rate [57].  
The dosimetric properties for a Varian a-Si EPID when operated in integrated mode are 
well–documented. The a-Si EPID response had different responses from that measured by an 
ionization chamber. Therefore to convert EPID image to dose, a number of corrections  were 
required [40, 61]. While the investigation of the use of EPID in integrated mode has been 
expansive, comparitively few investigations have been reported the influence of cine acquisition 
mode on the dosimetry of a Varian a- Si EPID. 
What has been established is that an EPID’s response when operated in cine mode has a 
reproducibility within ±0.8% (2 SD), and linearity with dose and dose rate within ±1% (2SD) for 
delivering 100 to 500 MU [163]. However, the nonlinearity with low MU was observed for dIMRT 
and VMAT deliveries. Longitudinal non-uniformities causing temporal fluctuations at the centre 
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of the EPID were observed with the VMAT technique. In addition, the central axis dose response 
of the EPID in cine mode is shown to stabilize after several images [56, 57]. 
As dosimetric application of the EPID operated in cine mode increases [55, 126, 163], the 
influence of cine acquisition mode on the EPID dosimetric characteristics requires further research 
as the few studies that have been conducted primarily focused on reproducibility, linearity with 
high delivered dose, and uniformity across the image. This study aims to investigate whether or 
not  cine acquisition mode will impact on the EPID’s dosimetric performance, including factors; 
the delivered dose, dose rate, MLC speed, field size, phantom thickness and common IMRT fields. 
This study includes an assessment of the performance of cine acquisition mode against the well-
documented integrated acquisition mode and dose measurements using an ionization chamber. 
3.2 Method 
A clinical a-Si-500 EPID was fixed to a Varian linear accelerator 21iX (Varian Medical 
Systems, USA), which has the 120-leaves of the Millenium MLC (5 mm leaf width) and produced 
a nominal photon energy of 6 and 18 MV. EPID attached to the retractable arm (E- arm type) 
connected to the gantry. The EPID had a sensitive area of 40´30 cm2 divided into 512´384 detector 
elements, yielding a pixel pitch of 0.784 mm.  
The EPID was irradiated with photons of 6 and 18 MV using a dose rate of 600 MU/min. 
The EPID was positioned at 150 cm SDD, and the gantry and collimator were set to zero unless 
otherwise specified, See Figure 3.1. The EPID images were acquired using the acquisition IAS3 
software (version 8.2.03), and calibrated according to the manufacturer's protocol [164]. The 
42 
 
calibration included DF and FF images. The DF image was acquired by averaging 30 frames during 
the beam off in order to measure the background electronic noise which needs to be removed from 
the resultant signal. The expected magnitude of this correction is ~5% [164]. The FF image was 
obtained by irradiating the entire EPID active matrix to an open field of radiation and is used to 
determine the relative pixel sensitivities. The magnitude of this correction is up to ~40% [164]. 
The FF correction was determined by averaging 200 frames. The example of DF and FF images 
showed in Figure 3.2. Calibrated images are calculated by the following equation [164]: 
 !(#,%) = (()*+(,,-)	/	01(,,-)11(,,-) 	) × 334567   (1) 
where !(#,%) is the calibrated value of an individual pixel i, j 
!869(#,%)  is the raw image  
:3(#,%) is the DF image 
33(#,%) is the FF image 
334567  is the mean pixel value from the FF image 
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Figure 3.1: Illustration of experiments setup with EPID, the source to detector  distance (SDD) is 150 cm. 
For acquisition parameters, Trigger delay was set to 6 ms, which was the waiting time 
between the beam pulse capture and the start of row scanning. BeamOnDelay was set to 0 ms that 
means all beam pulses from the beam were captured. The frame rate for cine mode was 12.8 and 
8.001 frame/sec for dose rates of 600 and 400 MU/min respectively. The number of frames per 
image was one. 
EPID images were exported in digital imaging and communication in medicine (DICOM) 
format and analysed using MATLAB (VR2012 b). It was noticed that the IAS3 system assigns 
high values to non-irradiated pixels (red colour) in calibrated EPID images and progressively 
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lowers values to pixels receiving higher doses (blue colour). To create a positive correlation 
between dose and pixel intensity, the whole image was inverted mathematically (Figure 3.3). 
In each image, the response of the EPID was determined through mean pixel intensity 
values in a region of interest (ROI), 11´11 pixels at the centre of field. The standard deviation 
represented the intensity between these pixels for a given image. As cine mode generates several 
images for a given MU, total dose was calculated by summation of pixel values over total acquired 
images. 
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Figure 3.2: An example of the dark field (DF) image (upper panel) and the flood field (FF) image (lower 
panel) aquired for a photon energy of 6 MV and dose rate 600 MU/ min. 
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Figure 3.3: EPID image obtained  after calibration by the dark field (DF) and the flood field (FF) images 
for delivering a field size of 10×10 cm2 with 100 MU using a photon energy of 6 MV and dose rate of 600 MU/min. 
The upper panel; shows higher intensity pixel values (red colour) correspond to non-irradiated pixels (where lower 
intensity pixel values are depicted in  blue colours). The lower panel shows an image inverted using MATLAB 
where the higher intensity values correspond to a high delivered dose value (red colour) and low intensity values 
correspond to non-irradiated pixels (blue colour). 
47 
 
3.2.1 Dosimetry Characteristics 
3.2.1.1 Linearity with Delivered Dose 
Photons of 5, 10, 15, 20, 25, 30, 40, 50, 60, 75, 90, 100, 200, 300 and 400 MUs were 
delivered for a field size of  10×10 cm2  for photon energies of 6 and 18 MV at dose rates of 600 
and 400 MU/min. Linearity was defined as the reduction of central pixel value/MU normalized to 
the value for the maximum MU of irradiation for each beam [57]. Further analysis was conducted 
to evaluate the number of acquired cine images in each MU delivery with different dose rates and 
a constant frame rate. The number of images acquired in each MU delivery was normalized to the 
maximum MU setting. To calculate missing images, the numbers of acquired images in each MU 
delivery were subtracted from the expected acquired images. Expected acquired images were 
derived from delivery time per irradiation and the frame rate (calculated manually based on the 
dose rate). The calculations of missing images in each delivery were averaged for each dose rate.  
3.2.1.2 Stability at Start of Acquisition 
The stability of cine mode response with respect to the acquired image number was 
examined.  A field size of 10×10 cm2 was delivered ten times using a 100 MU for 6 MV photon 
beam and a dose rate of 600 MU/min. The deliveries were repeated for a dose rate of 400 MU/min. 
3.2.1.3 Reproducibility 
Short term reproducibility of cine mode was evaluated by delivering a MU of 100, 200 and 
300 for a field size of 10×10 cm2 using a photon energy of 6 MV. These deliveries were repeated 
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three times with 10 minute time intervals. For the assessment of long term reproducibility, these 
measurements were repeated three times with two month’ time intervals.  The reproducibility was 
assessed by recording averaged normalized pixel values and standard deviations for three 
deliveries at a given MU.  
3.2.1.4 Dose Rate Dependence 
The distance from source to EPID sensitive layer was varied from 10, 20, 30, 40, 50 and 
60 cm below the isocenter. For each distance, an image for a field size of 10×10 cm2 was acquired 
for delivery of 10 MU. All results were normalized to the values of maximum distance.  
3.2.1.5 Multileaf Collimator Speed Dependence 
Dynamic MLC deliveries were performed with a uniform 1 cm leaf gap between the two 
banks of MLC leaves for a 10×10 cm2 field. The leaf speed was changed by varying the number 
of MU from 600 to 40; results were normalized to those of the minimum MLC speed. 
3.2.1.6 Field Size Dependence 
Open square fields of side of 4, 5, 8, 10, 12, 15 and 20 cm were delivered with 100 MU.  
Results were normalized to the response obtained at  the maximum field. 
3.2.1.7 Phantom Thickness Dependence 
Homogeneous solid water slab phantoms (RW3, Type 29672, PTW) varying in thickness 
between 0.2 to 15 cm were placed on the treatment couch with the EPID panel and the gantry was 
positioned at 270°. Care was taken to minimize the air gap between the EPID and slab phantoms. 
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All measurements were delivered with 100 MU for photon energies of 6 and 18 MV using a field 
size of 10×10 cm2. The results were normalized to those of the maximum thickness. 
3.2.1.8 Intensity Modulated Radiation Therapy Delivery 
A clinical dynamic IMRT prostate plan was delivered using 6 MV and a dose rate of 400 
MU/min. The cross profile through the central axis of summation cine images for each field were 
examined. 
3.2.2 Cine Mode vs Integrated Mode & Ionization Chamber Response 
Measurements were repeated using the integrated acquisition mode. The integrated dose 
for a given MU was calculated by multiplying the mean pixel value at ROI by the number of 
frames acquired [64]. Measurements were also performed using a CC13 ionization chamber 
(Thimble chamber CC13, Scanditronicx Wellhofer, IBA), which is the standard chamber for 
clinical use in connection with an electrometer. It has an active volume of about 0.13 cm3   and an 
inner radius of 3 mm. It was positioned on the beam central axis at a depth of 1.5 and 3 cm for 6 
& 18 MV, respectively (see Figure 3.4). Measurements were repeated twice. For a graphical 
comparison between EPID operated in cine and integrated modes, and ionization chamber 
measurements, all results were normalized to detector response.  
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Figure 3.4: Illustration of experiments setup  with ionaztion chamber. Source to detector distance (SDD) is 
150 cm. Ionaztion chamber postioned at at a depth of maximum dose of  1.5 cm for a photon energy of 6 MV, and 3 
cm for a photon energy of 18 MV. 
3.2.3 Absolute Pixel Value of Image 
Previous dosimetry characteristics were evaluated using normalized responses. The 
absolute response of cine mode was shown as it is required for the conversion of signal to dose. 
100, 200 and 300 MU were delivered using a field size of 10×10 cm2 at a dose rate of 600 MU/min 
for 6 and 18 MV with a constant frame rate.  
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3.3 Results  
3.3.1 Dosimetry Characteristics 
3.3.1.1 Linearity with Delivered Dose 
Figure 3.5 illustrates the response of the EPID operated in cine and integrated acquisition 
modes and ionization chamber response for a range of MU. Results were normalized to the detector 
response at maximum MU setting. A logarithmic scale was used for clearer visualization. When 
delivering 5 MU using a photon energy of 6 MV the image acquisition software was unable to 
provide images for cine mode, therefore, the graph shows the response of cine mode starting from 
10 MU. 
It was shown that EPID using cine mode has a nonlinear response for small MU at both 
energies, when 10 MU was delivered the response of EPID was about 0.5 and 0.64 for photon 
energies of 6 and 18 MV respectively. In contrast, responses of EPID using the integrated mode 
and ionization chamber for delivery using the same MU for 6 MV were 0.95 and 1.01 respectively. 
The response of EPID using cine mode with an increased MU became linear and comparable with 
the integrated mode and ionization chamber, i.e. within < 2%, when delivered at 100 MU.  
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Figure 3.5: Response of a-Si EPID (cine and integrated modes) and ionization chamber for deliver dose 
with dose rate 600 MU/min and 6 MV & 18 MV, logarithmic scale was used. Error bars are the same size or smaller 
than the symbols used. 
The correlation between EPID response operated in cine mode and the corresponding 
number of acquired images in each MU delivery as a function of dose rate is illustrated in Figure 
3.6. EPID response at each delivery was consistent with the corresponding number of acquired 
cine images in that delivery, and both EPID response and corresponding number of images had 
nonlinear trend for arrange of MU for both dose rates. The degree of nonlinearity for 600 MU/min 
was higher compared to 400 MU/min, with differences of 12.29% for a delivery of 20 MU. 
 In addition, the missing images were calculated to be four images in each delivery for both 
dose rates. It should be mentioned that the above calculation ignored the effect of Trigger delay 
on frame rate. Furthermore, it was assumed that beam output is constant at particular dose rates.  
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 Figure 3.6: Cine mode response for dose delivering with dose rates of 600 and 400 MU/min using a photon 
energy of  6 MV and a constant frame rate. Corresponding number of cine images acquired for each dose delivery 
were plotted, error bars are the same size or smaller than the symbols used. 
3.3.1.2 Stability at Start of Acquisition 
The stability of the central axis EPID response in cine acquisition mode was examined as 
a function of image number (see Figure 3.7). The central axis dose response used in these 
calculations resulted from averaging ten measurements.  For both dose rates, the central axis dose 
exhibit increases over the first acquired images with high standard deviation, noticed peaks around 
image number equal to ten. The Central axis response increased by 2.1% and 4.3% for dose rates 
of 600 and 400 MU/min respectively with standard deviations equal to ±59.6% (1 SD) and  ±42% 
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(1 SD). Stability occurred after acquisition of ~ 30 images for a dose rate of 600 MU/min and 20 
for a dose rate of 400 MU/min.  
 
 
Figure 3.7: Stability of central axis EPID signal during ten trials of 100 MU delivery for  a field size of 
10×10 cm2 using a photon energy of  6 MV with a dose rate of 600 and 400 MU/min, error bares represented 
standard deviation of ten measurments for corresponding image number. 
3.3.1.3 Reproducibility  
Reproducibility was assessed by averaging three mean pixel values at the centre of images 
acquired using cine and integrated mode for different MU with time intervals of 10 minutes (short 
term) and two months (long term). Generally, EPID with cine and integrated mode showed good 
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reproducibility for both short and long term time intervals. The EPID reproducibility using both 
modes were less than ± 0.2% (1 SD) for most cases in short and long term. 
3.3.1.4 Dose Rate Dependence 
The EPID response of cine mode and integrated modes as a function of distance from 
source for both 6 and 18 MV energy is presented in Figure 3.8. Data were normalized to the value 
of maximum distance. The results from this experiment demonstrated that when 10 MU are 
delivered, the response of EPID operated in cine mode is well matched with the integrated mode 
and ionization chamber responses within 2% for both photon energies.  
 
 
Figure 3.8: Response of the EPID in cine and integrated acquisition modes and ionization chamber 
measurements as function in dose rate with delivery of 10 MU, error bars are the same size or smaller than the 
symbols used. 
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3.3.1.5 Multileaf Collimator Speed Dependence 
The results presented in Figure 3.9 show the normalized EPID response of cine and 
integrated modes as well as ionization chamber response with respect to change in MLC speed at 
the center of field size 10×10 cm2. A logarithmic scale was used for clearer visualization.  
EPID using cine mode has a response similar to using the integrated mode and ionization 
chamber measurements for a range of MLC speeds between 0.17 to 2.8 cm.s -1. However, EPID 
operated in both modes had a slightly lower response compared to ionization chamber at a higher 
MLC speed. The maximum deviation between cine mode response and ionization chamber was 
2.9% for 18 MV at 2.8 cm.s -1 . 
 
Figure 3.9: Response of the EPID in cine and integrated acquisition modes for changing MLC speed with 
corresponding dose measurements for 6 MV and 18 MV, a logarithmic scale was used, error bars are the same size 
or smaller than the symbols used. 
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3.3.1.6 Field Size Dependence 
Figure 3.10 illustrates the ratios of EPID operated in cine and integrated modes to 
ionization chamber as a function of field size. Results were normalized to the detector response at 
value for a maximum field size. The ratios of EPID to ionization chamber as a function of field 
size showed that cine mode has a comparable response with the integrated mode with a difference 
of less than 1% at both energies. 
 
 
Figure 3.10: The ratio of EPID operated in cine and integrated modes to ionization chamber response with 
changing field size using a dose rate of 600 MU/min for 6 MV and 18 MV, error bars are the same size or smaller 
than the symbols used. 
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3.3.1.7 Phantom Thickness Dependence 
The normalized EPID response of cine and integrated acquisition modes at the centre of 
field size of 10 x10 cm2   were determined as a function of solid water thickness at photon energies 
of 6 and 18 MV (Figure 3.11). Measurements using ionization chamber at a maximum depth dose 
were also determined. Data were normalized to the values obtained at a maximum thickness.  
The EPID response operated in both modes with respect to phantom thickness were 
comparable within a difference of 1.5%, and the build-up region did not appear entirely with 6 
MV. However, it was mostly visible with 18 MV. EPID response after a build-up region around 
3.5 cm was comparable with the ionization chamber within 1%.   
 
Figure 3.11: The response of the EPID operated in cine and integrated acquisition modes with the respect 
of phantom thickness using dose rate 600 MU/min, dose measurements using ionization chamber are included, error 
bars are the same size or smaller than the symbols used. 
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3.3.1.8 Intensity Modulated Radiation Therapy Delivery 
A good agreement was obtained between normalized cross profiles at the centre of field of 
cine and integrated images for clinical IMRT fields. IMRT fields are shown in Figure 3.12. 
3.3.2 Absolute Pixel Value of Image 
The mean pixel value of images using cine and integrated modes were within 2% for cine 
and integrated mode for 200 and 300 MU for a given energy, while for 100 MU the mean pixel 
value of cine images was 5% less than integrated images, (see Figure 3.13).  The mean pixel value 
of images was higher with 6 MV compared to 18 MV. 
 
 
 
 
 
  
60 
 
 
 
 
Figure 3.12: Normalized cross-plane profiles along the central axis for clinical IMRT fields acquiring using 
EPID operated in cine and integrated mode.  
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Figure 3.13: Mean pixel value at the centre of images acquired using a-Si EPID with integrated and cine 
mode for photone energies of 6 and18 MV, error bars are the same size or smaller than the symbols used. 
3.4 Discussion 
The nonlinearity of EPID response with low MU when used in cine acquisition mode was 
reported to be due to dose rate irregularity [57] or the missing of four images quantified by the 
frame-grabber system [56]. In this study, results were shown that the nonlinearity of the EPID 
response was due to missing acquired cine images in each delivery. The four images that were lost 
were quantified by calculation based on the frame rate and dose rate used. The missing images 
occurred at each acquisition session, but with increases in the delivered dose the impact of the 
missing image made less contribution compared to the total delivered dose. While the number of 
missing images was similar for each dose rate, the degree of nonlinearity was higher with a higher 
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dose rate. This is because the dose per image in the acquisition system increases automatically 
with increased dose rate with the result that the effect of missing images will be more significant 
at a high dose rate. For dosimetry applications, based on the finding in this study it is recommended 
that the calibration of the EPID should be run at large MU to minimise the impact of missing 
images. Furthermore, when the IMRT verification field has a low MU (less than 100 MU) and a 
high dose rate, correction for missing images is required. Missing images could be compensated 
by quantifying the dose equivalent for four images then adding this dose in each field. 
Results presented in Figure 3.7 demonstrated that the central axis response of EPID images 
become stable after acquisition of between 20 and 30 images depending on the dose rate. Changing 
the BeamOnDelay parameter may improve the stabilization of the central axis of EPID images 
however the BeamOnDelay setting of zero gave the best improvement in the linearity of the cine 
mode for the delivered dose [56]. 
To investigate the effect of changing the dose rate for very low MU (10 MU) while keeping 
the dose per image constant, the dose rate was changed by changing SDD. An EPID operated in 
cine mode showed a comparable response to its response using integrated mode and an ionization 
chamber. The comparison in performance confirmed that changing the dose rate does not have 
influence on the EPID response using cine mode, and that nonlinearity was caused by missing 
images.  
Because the accelerator  may reduce the dose rate, in case the MLC cannot reach a pre-
defined position with maximum leaf speed, large dose-rate variations during dynamic IMRT or 
VMAT delivery are possible [41]. Results showed that cine mode can record the rapid temporal 
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changes in dose rate that occur during dynamic MLC deliveries with performance similar to 
integrated mode and the ionization chamber. The slightly lower response of the EPID operated in 
cine mode to ionization chamber is not related to the cine mode itself as integrated mode has a 
similar lower response. This may explained by the different physical structure of EPID with respect 
to MLC-transmitted radiation and the response of the EPID to MLC-transmitted radiation  
compared to open beams due to the removal of low energy photons by the MLC [68, 76]. This 
result validates the suitability of cine mode for delivery including rapid changes in dose rate such 
as VMAT delivery.  
Results for output factor, phantom thickness, and common IMRT fields showed that using 
cine mode doesn’t influence EPID performance, and both integrated and cine modes deviated from 
the ionization chamber response. The reason for the EPID  deviation using integrated mode has 
been explained in detail previously as being mainly due to the presence of a phosphor layer [61, 
75]. Results for EPID in both modes indicated that no extra correction is required for converting 
the EPID to dose when using cine mode, and we can use the integrated mode to extract correction 
factors. 
Absolute pixel values for EPID operated in cine mode were slightly lower compared to 
using the integrated mode for delivering 100 MU. This may be explained due to missing images 
with the use of cine mode. Absolute pixel values for the EPID decreased with an increase in energy 
for both modes. This may return to the results in Figure 3.11 showing that the signal of the EPID 
for 6 MV was higher due to the limited build-up region being more adequate compared to 18 MV. 
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The equivalent material in front of the EPID is 8 mm [61]. Therefore, for dosimetry applications 
the absolute pixel value was dependent on the photon energy used.  
3.5 Conclusion 
This study examined the dosimetric response of a Varian EPID when using cine acquisition 
mode specifically with delivering a low MU and changing dose rates. Nonlinearity of the EPID 
response with low MU operated in cine mode is dependent mainly on the dose per frame, which 
was influenced by the selected dose rate. Therefore, to avoid the effect of missing images for 
dosimetry applications, calibration of the EPID images using cine mode to convert signal to dose 
should be run at large MU, and when the IMRT verification field has a low MU (less than 100 
MU) and a high  dose rate is used, a correction of missing images is required. Despite nonlinearity, 
results confirmed the efficiency of cine mode with rapid variation in dose rate such as VMAT 
delivery. In addition, EPID performance including: dose rate, MLC speed, field size, phantom 
thickness, IMRT field, absolute pixel value using cine mode has a comparable response to its 
response using the well-documented integrated acquisition mode. It is indicated that for dosimetry 
applications no further correction factors for these properties are specifically required for EPID 
when operated in cine acquisition mode, and the possibility of using similar correction factors for 
both acquisition modes was confirmed in this study. This may minimize the workload related to 
derive correction factors.   
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Chapter 
4 Develop Transit Dosimetry using an a-Si 
EPID based Measurement Approach  
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4.1 Introduction 
The EPID response is well documented as a non-water equivalent response, and the main 
limitations to the use of EPID in dosimetry applications have been identified as the clinical FF 
calibration, hypersensitivity to low energy photons, and backscatter from the EPID arm. The aim 
of this literature review is to consider the approaches proposed to overcome each of these 
problems. The accuracy of the proposed approaches cannot be compared directly because of the 
considerable variation in the design of the relevant studies (e.g., type of delivered field, criteria 
used, etc.). 
Clinical FF calibration has been addressed by two methods. One method replaced a clinical 
FF image with one acquired at a condition that can generate a flat profile. The FF image was 
acquired either experimentally by adding 2 cm of solid water to the EPID panel [104], by adding 
10 cm of solid water [40], or by modeling 2.5 cm of water-equivalent plastic using MC simulation 
[99]. Instead of the acquiring the FF image with sufficient build-up material, Greer [67] showed 
that a flat FF image can be obtained by delivery of a series of small fields in different locations on 
the EPID panel, termed a pixel sensitivity matrix (PSM). This was conducted either experimentally 
[67] or by MC simulation [78]. However, this method required extra correction for the off-axis 
variations. 
The second method maintained a clinical FF image but post-processing calibration was 
applied by multiplying the EPID image with a dose profile where the horn effect was represented. 
A dose profile was measured using an ionization chamber in air [136], at a depth of 1.5 cm [125, 
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165], or in 5 cm of water [101], by using film at a depth of 0.8 cm [61], or by calculations using 
TPS [80]. 
The hypersensitivity of the EPID response was overcome by using a number of different 
solutions. To control the hypersensitivity that was caused the energy spectrum dependence, the 
removal of the phosphor layer from EPID structure was suggested [95, 106, 111, 166, 167]. 
Moreover, an opaque sheet was inserted into the EPID structure to prevent the optical photons 
from reaching the photodiodes [75]. However, the current clinical EPID is not equipped with these 
features. Adding build-up material can reduce the variation in EPID response between the on-axis 
and off-axis distances [63, 68]. An alternative approach has been to model the energy fluence using 
TPS [71] or MC [99]. 
Field size dependence was resolved by deriving the field size kernel experimentally [74, 
104, 125] or using MC simulation [104]. Instead of modeling the EPID field size dependence, Lee 
et al. [101] used TPS to determine the optimal depth in water where the scatter characteristics in 
EPID has a similar behavior to the scatter in water. The optimal depths for EPID calibration were 
5 cm and 3 cm for photon energies of 6 and 18 MV, respectively. 
To resolve phantom thickness dependence, the energy spectrum variation was modeled 
experimentally as a function of different absorber thicknesses [74] or by MC simulations [116]. 
An alternative method was to include the effect of phantom thickness and to calculate the 
transmission correction based on CT images [100]. 
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For the MLC effect, the use of a separate correction factor for the primary photon and 
transmitted photon was proposed, and the correction factor was obtained from measurements 
against the ionization chamber in the center of the field [59] or MLC file in the TPS [77]. Another 
proposal was to calculate separate kernels for the MLC and for open fields using MC simulation 
[78]. Further studies calculated the correction factor for the MLC transmission effect, as well as 
for tongue and groove and interleaf transmission beams. The correction was calculated using the 
TPS [168] or MC simulation [96].  
For the backscatter issue, a number of studies proposed solutions that involved removal of 
the backscatter radiation from the supporting arm. The insertion of lead under the EPID panel was 
suggested, with thicknesses of 5 mm [169] or 2 mm [83]. However, this solution may introduce 
positioning and reliability problems for the EPID panels due to increases in the imager weight. 
The employment of kernels was also suggested to account for the effect of backscatter, using MC 
simulation [170] or experimentally [71, 171]. The effect of backscatter was quantified 
experimentally by comparing the case where the arm was on (clinical setup) and after extracting 
the EPID panel from the arm (research setup). The combination of the two previous solutions was 
also examined, where a small layer of lead was added only to the area of interest on the EPID that 
affects the dosimetry, and the remaining backscatter radiation was modeled [85]. Berry et al. [172] 
quantified the difference between the gun and target sides to extract the required correction. 
Recently, Varian has produced a modified backscatter shielded EPID that contains a sheet of lead 
under the EPID panel. This shield reduces the effect of the support arm backscatter to less than 
0.5% [42, 102]. However, this type of shield is not yet widespread in clinics.  
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The related work by others to convert EPID transit images to doses clearly shows a strong 
reliance on MC simulation modeling or kernel application. These approaches provide accurate 
transit dosimetry results; however, routine experience on EPID for transit dosimetry in the clinical 
setting is limited mainly because of the complexity of reproducing the published methods. MC 
calculations are time consuming and computer resource intensive, and the application of a kernel 
requires a degree of experience in mathematical optimization.  
In 2014, Sabet et al. [135] from the Newcastle group developed a measurement based 
approach that uses neither kernels nor MC simulation to obtain 2D transit dosimetry. They 
calibrated the EPID response at the in-field area using a number of corrections, including removal 
of the FF clinical calibration, application of PSM, combination of the effects of off-axis distance 
and phantom thickness, and combination of the effects of field size and phantom thickness. The 
aim of the present study is to develop the method proposed by Sabat using a novel in-field area 
correction that allows calibration of the in-field area of the EPID response in a single step, rather 
than through a number of corrections. The EPID dose model developed using this approach is 
further validated by comparing the transit dose measured by a MapCHECK dosimetry system for 
delivering dIMRT fields. 
4.2 Method 
This chapter describes how 2D transit EPID images are converted to a 2D equivalent water 
dose in a plane at the depth of maximum dose at the EPID level. The experiments include three 
parts: the determination of the build-up thickness, extraction of the corrections required to convert 
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EPID images to doses, and verification of the conversion method against the well-established 
MapCHECK dosimetry system. 
All measurements were acquired using a Varian aS500 EPID. The EPID was fixed to a 
Varian Clinac 21iX linear accelerator (Varian Medical Systems, Palo Alto, USA), as detailed 
above (section 3.2). The cine acquisition mode was utilized, and for a given irradiated field, 
multiple cine images were acquired and summed to produce a single image. The response of the 
image was determined through mean pixel intensity values in ROI, 11×11 pixels, at the center of 
field. 
EPID images were calibrated according to the manufacturer's protocol, including DF and 
FF calibrations [164]. Measurements in this chapter were performed using a photon energy of 6 
MV, with a dose rate of 600 MU/min, a delivery of 100 MU at SDD of 150 cm, and the gantry set 
to zero, unless otherwise specified. All corrections were extracted using jaw defined field sizes, 
and the measurement included the treatment couch. 
A CC13 ionization chamber (Thimble chamber CC13, Scanditronicx Wellhofer, IBA) was 
use ~0.13 cm3 and an inner radius of 3 mm. It was connected to an electrometer to provide point 
dose measurements. It was also used to provide the relative dose profile scanned in a 50×50×50 
cm3 water tank (Blue Phantom, IBA Dosimetry GmBH, Schwarzenbruck, Germany); another 
chamber was used with the water tank as a reference point in the field. All measurements were 
conducted at the depth of the dose maximum (1.5 cm). Measurements were repeated twice, except 
for the scan of the dose profile, which was performed once. The ionization chamber was calibrated 
according to clinical protocols [173]. The solid water slab phantoms (RW3, Type 29672, PTW), 
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each with an area of 30×30 cm2, were used to extract the correction factor. Copper (Cu) sheets 
were used to select the required external build-up thickness. 
4.2.1 External Build-up Thickness 
The EPID has inherent build-up material (a Cu plate and a scintillator screen), but adding 
external build-up material is recommended when the EPID is used for transit dosimetry 
applications. The build-up material serves to obtain measurements that are made beyond the dose 
maximum (i.e., the electronic equilibrium) and absorbs low-energy photons. McDermott et al. [63] 
showed the advantage of employing Cu rather than polystyrene for EPID with the range of energy 
of 4, 6, 8, and 18 MV .The cross section of Cu makes it a good absorber for low energies of less 
than 100 KeV [63].  
In this study, Cu thicknesses of 0, 0.55, 1.65, 2.2, and 2.5 mm were examined. The main 
approach used to determine the required thickness of build-up material for transit dosimetry has 
been explained previously [30]. The effect of the air gap between the phantom and the EPID was 
verified. The Cu thickness was increased until the EPID response became consistent with the 
ionization chamber measurement. The EPID panel was irradiated using a field size of 10×10 cm2. 
All measurements were performed under a 20-cm-thick solid water phantom positioned with its 
exit surface 100 cm from the source. The source-to-sensitive-layer of the EPID was changed from 
120 to 150 at 10 cm intervals. The center of the EPID panel was located on the central axis of the 
beam. Point dose measurements were taken with the identical setup using an ionization chamber 
(see Figure 4.1). A water equivalent thickness of 10 cm was placed under the ion chamber to 
include back scatter to maintain a full scatter condition to the ion chamber. The Cu thickness that 
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provided the best agreement between the EPID and ionization chamber responses was selected as 
the external build-up thickness added to the EPID panel for this project. 
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Figure 4.1: Experimental setup for the selection extra build up thickness; detectors are positioned at a 
source to detector distance (SDD) =150 cm, 100 MU using a field size 10×10 cm2 with a photon energy of 6 MV 
delivered through a solid slab phantom (a thickness of 20 cm). The treatment couch was positioned at SSD =110 cm. 
a) EPID and Cu sheet measurement, b) ionization chamber measurement. 
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4.2.2 Corrections to Convert Transit EPID Image to Transit Dose 
Raw transit EPID images, which were clinically calibrated by the FF image, were multiplied 
pixel by pixel with a 2D backscatter correction matrix. The images were then multiplied pixel by 
pixel by a 2D in-field area correction. The resulting images then had an out-of-field correction 
factor subtracted. Finally, the relative dose images were multiplied by an absolute dose calibration 
factor (see Figure 4.2). 
 
 
Figure 4.2: The dosimetric calibration to convert a transit EPID image to a water-based dose distribution at 
a maximum dose and a depth of 1.5 cm. 
4.2.2.1 EPID Arm Backscatter Correction 
Most of backscatter from the arm exists in EPID images at the in- plane profile [30]. Berry et 
al. [172] removed arm backscatter for pre-treatment verification using an approach based on the 
assumption of symmetry between the gun and target side. A symmetric image for each field size 
was generated by reflecting the gun side about its central row of the raw image. The correction 
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matrix was then calculated as a decrease in response, on a pixel-by-pixel basis, that needed to be 
applied to the row of the EPID image to create a symmetric EPID image. 
We extended this approach for application to transit dosimetry. EPID images at 150 cm 
were acquired for jaw defined field sizes of 5×5 to 20×20 cm2. Fields were delivered using 100 
MU with a dose rate of 600 MU/min for a photon beam of 6 MV. For each field size, a correction 
matrix was calculated and designed. The efficiency of this correction was examined by comparing 
in-plane profiles after application of a correction to cross profiles for a field size of 5×5, 10×10, 
15×15, and 20×20 cm2. 
4.2.2.2 In-Field Area Correction 
The in-field region is defined as the area where the signal is over 50% of the maximum 
signal [174]. EPID images were acquired at a SDD of 150 cm for delivering 100 MU using a jaw 
defined field of 20×20 cm2. Measurements were conducted with phantom thicknesses of 0, 5, 10, 
15, and 20 cm. Cross plane profiles at the central axis of the field were extracted for each EPID 
image. Under an identical setup, the cross profiles at the center axis of the field was scanned in a 
water tank using an ionization chamber (see Figure 4.3). 
All profiles were normalized to the central axis. Ionization chambers and EPID profiles 
have different resolutions; therefore, to compare the data, each profile was interpolated to 0.1 mm 
using a spline method. For a given phantom thickness, the ratio of the normalized ionization to 
EPID profiles was calculated. For a given ratio profile, preliminary results showed a slight 
fluctuation between the corresponding points on each side of the center of the profile (e.g., at the 
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off-axis distance). Therefore, the corresponding points on each side were averaged and a standard 
deviation was calculated.  
To obtain the 2D in-field correction matrix for a given thickness, each data set was 
interpolated and fitted using the spline method, and then copied in a radially symmetrical manner 
[101]. Note that the length of the cross profile was around 15 cm from center, so it was slightly 
extended in both directions (right and left from the center). This was done to cover the whole panel 
and to ensure that the correction would apply for any field size. 
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Figure 4.3: Setup experiment using an ionization chamber in a water tank to scan a cross profile for varying 
phantom thickness and field sizes, a) EPID measurement, b) ionization chamber positioned at a source-to-detector 
distance (SDD) =150 cm at a depth of 1.5 cm in a water tank. 
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The effectiveness of this correction was tested by comparing ionization chamber and EPID 
profiles for various field sizes and phantom thicknesses. In-house 1D 
gamma analysis using MATLAB software (VR2012 b) was used to compare the ionization 
chamber and EPID profiles before and after application of the in-field area correction. Gamma 
analysis is the gold standard for comparisons between two dose distributions. It takes into 
consideration the dose difference and the spatial displacement between analyzed points to provide 
a gamma pass rate. The gamma pass rates are percentages of points meeting the criteria, which 
indicate the level of agreement between the dose distributions [175]. In this study, a percentage of 
3% represents a tolerance of a dose difference, and 3 mm represents a tolerance of the distance to 
agreement, which was selected because it is commonly used in clinical settings [176]. The 
threshold is the dose value above which all field results are included in the analysis, so all dose 
values were included for comparison. A global gamma analysis was applied that calculated the 
percentage dose difference relative to the maximum dose in the measurement field. 
4.2.2.3 Out-of-Field Area Correction  
After application of the correction detailed in Section 4.2.2.2, the difference in the out-of-
field region was noticeable. To extract the correction required for the out-of-field region, the 
differences at the tails between the EPID and dose profiles were calculated. These differences were 
converted into percentages of the maximum values of whole images [135].  
The profiles were acquired for a range of field sizes (5, 10, 15, and 20 cm2) and phantom 
thickness (0, 5, 10, 15, and 20 cm). The correction was calculated for each combination between 
a given phantom thickness and a given field size. The 1D gamma evaluation was used to test the 
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efficiency of this correction with using a 3%3mm criteria and all dose values were included for 
comparison.  
4.2.2.4 Absolute Dose Calibration Factor  
All previous corrections were derived as a relative correction (normalization value). The 
absolute correction factor was required to convert the relative dose EPID images to absolute doses. 
This factor converts an EPID image from intensity units to cGy for a field size of 10×10 cm2, 
measured by the ionization chamber and EPID at SDD of 150 cm, for delivering 100 MU. The 
ionization chamber readings were converted from nC readings to absolute dose values. 
4.2.3 Validation of the Transit EPID Dosimetry-based Measurement Approach 
The converted EPID dose distributions for clinical 30 dIMRT fields from three head and 
neck (H&N) and two prostate cases were verified. EPID images at 150 cm under an 
anthropomorphic phantom (Alderson RANDO, USA) were acquired for each field. 
The MapCHECK™ system (Sun Nuclear Corporation, Model 1175, Florida) was calibrated 
according to the manufacturer’s guidelines [177], and then used to acquire dose maps using the 
same beam geometry as used with the EPID. The MapCHECK has been reported to be a reliable 
tool for IMRT treatment verification [178, 179]. According to the manufacturer, the MapCHECK 
contains 445 silicon (n-type) diodes detectors arranged in an octagonal grid area of 22×22 cm2. 
The grid contains two portions: the center portion has an area of 10×10 cm2 with 7.07 mm detector 
spacing, and the outer portion has 14.14 mm detector spacing. The diode layer has a 2 cm thick 
water-equivalent build-up material and a 2.3 cm thick water-equivalent backscattering material. 
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The measurement area of the MapCHECK is smaller than the measuring area of the EPID. 
Therefore, we have only selected the size of field that can be covered by the MapCHECK, so the 
lung field was not examined as it is mostly larger than the MapCHECK size at the level of 150 
cm. The gantry degree was set to zero for all delivered fields. This decision was made to prevent 
errors in measurement due to the sagging of the EPID [50]. 
In addition, because the EPID and MapCHECK have different resolutions, both dose 
images had to be interpolated to a dose grid of 0.1 mm. In addition, the MapCHECK has a 2 cm 
thick water-equivalent build-up material, so there is a difference of approximately 0.5 cm in the 
thickness of the water-equivalent build-up material between our EPID dosimetry system and the 
MapCHECK. According to the baseline beam data (generated from linac during the 
commissioning process), the absolute dose at the maximum depth was reduced from 100% at 1.5 
cm to 98% at 2 cm. To prevent a systematic dose difference between the EPID and MapCHECK, 
an absolute correction factor for converting an intensity value to a dose value was extracted based 
on the reading from the MapCHECK at SDD = 150 cm when delivering 100 MU using a field size 
of 10×10 cm2 and a dose rate of 600 MU/min for a photon energy of 6 MV. 
In-house 2D gamma evaluation employing MATLAB (VR2012 b) software was used to 
compare the EPID and MapCHECK dose images. The criteria were 5%/3mm, 3%/3mm, 3%/2mm, 
3%/1mm, 2%/3mm, 2%2mm, and 1%/5mm using a threshold of 50% of the maximum field. 
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4.3 Results 
4.3.1 External Build-up Thickness 
Figure 4.4 illustrates the ratios of EPID to ionization chamber responses for different Cu 
thicknesses ranging from 0 to 2.5 mm. The results for each detector were normalized to the highest 
air gap (50 cm). Data were fitted using a quadratic polynomial curve (fitting details are given in 
appendix A.1). A few outliers were observed when fitting the data, especially for an air gap of 30 
cm.  
When no Cu sheet was present on the EPID panel, the ratio was higher than when the Cu 
sheet was added. The maximum ratio was 1.022 at an air gap of 20 cm. This means that the 
difference in the EPID and ionization chamber responses was more than 2%. The ratios were 
reduced to within 1.01 and 1 when a thickness of 0.55 mm was added to the EPID panel for all air 
gaps. The increase in thickness of the Cu sheet (1.65 to 2.5 mm) reduced the ratios, and the 
agreement between the EPID and ionization chamber came to lie within 1%.  
Adding Cu thicknesses of 1.65, 2.2, and 2.5 mm gave comparable responses for the EPID 
to ionization chamber ratios for delivery of 100 MU for a photon energy of 6 MV at different air 
gaps. Therefore, considering the benefit of a lighter weight for the Cu thickness on the EPID panel, 
a thickness of 1.65 mm was selected for all subsequent experiments as the external build-up 
thickness to add onto EPID panel when using a photon energy of 6 MV. 
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Figure 4.4: Ratio of normalized EPID to ionization chamber response for a given copper thickness as a 
function of the air gap distance. The copper thickness was added to the EPID. The EPID panel under a thickness of a 
20 cm solid water phantom. Beam was delivered using a 100 MU with a field size of 10×10 cm2 and a photon 
energy of 6 MV with a dose rate of 600 MU/min. The values are shown as data points. The solid lines represent the 
fit to the data points. 
The effect of adding the external Cu build-up material on the EPID profile is shown in 
Figure 4.5. Both thicknesses of 1.65 and 2.5 mm had similar effects on the EPID profile. The effect 
of Cu was more obvious at the in-field area, while only a slight impact was apparent on the out-
of-field region. The response of the EPID at the in-field area was reduced to 1.6% at an off-axis 
distance of 60 mm. At the out-of-field area, the penumbra region became more rounded. 
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Figure 4.5: The effect of applying additional Cu sheet thickness on the EPID beam profile at an air gap of 
50 cm for delivering 100 MU with a field size of 10×10 cm2. 
4.3.2 Corrections to Convert the Transit EPID Image to a Transit Dose 
4.3.2.1 EPID Arm Backscatter Correction 
Figure 4.6 shows an example of the raw EPID profile and a symmetric EPID profile and 
the associated correction matrix. The backscatter from the arm exhibits a higher response on the 
target side.  
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Figure 4.6: Example of a backscatter correction matrix for a field size of 8×8 cm2. This is created by 
calculating a decrease in the EPID response that needs to be applied to the row of the EPID image to create a 
symmetric EPID image. The black arrow indicates the analysis profile on the right side. The backscatter appears as a 
higher response on the target side compared to the gun side. 
The in-plane profiles in the center of each correction matrix were analyzed and plotted for 
a range of field sizes from 5×5 to 20×20 cm2 (see Figure 4.7). The data were fitted using linear 
regression (details of the fitting parameters are listed in appendix A.2). The analyzed profiles in 
the correction matrixes show that the magnitude of the correction depended on the field size and 
the position of the pixels from the centre of the imager. In general, the magnitude of the corrections 
increased with decreasing field size and for the pixels located farthest from the centre of the 
imager. The maximum percentage of correction required was 3% for a field size of 5×5 and 8×8 
cm2. With an increase in field size, the required correction was reduced and was nearly equal to 1 
for a large field size (20×20 cm2). 
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Figure 4.7: Profiles measured along the center of the correction matrixes for field sizes of 5×5 cm2 to 
20×20 cm2 with delivery of 100 MU and using a dose rate of 600 MU/min for 6 MV. Profiles plotted for the lower 
part of the correction matrix as the upper part is equal to one. The values are shown as data points. The dashed lines 
represent the linear fit to the data points. 
The efficiency of the backscatter correction obtained by comparing in-plane profiles and cross 
profiles for a range of field sizes after applying the backscatter correction is shown in Figure 4.8. 
The applications of backscatter correction matrixes diminished the higher response eveident in the 
in-plane profiles, which became comparable to the cross profiles. Except for a slightly discrepancy 
noticed for a field size of 10×10 cm2, this discrepancy was less than 1%. 
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Figure 4.8: A comparison between in-plane profiles and cross profiles through the EPID after application of 
correction matrixes for field sizes of 5×5, 10×10, 15×15, and 20×20 cm2.  
4.3.2.2 In-Field Area Correction 
Figure 4.9 and Figure 4.10 show the differences in-field areas between the ionization 
chamber and the EPID, and the 2D in-field correction matrix for phantom thickness (0, 5, 10, 15, 
and 20 cm2). The difference assessment by the ratio of the ionization chamber to EPID responses 
was normalized to the central value for varying phantom thickness with delivery to a field size of 
20×20 cm2. Error bars represent the standard deviation for averages of the corresponding ratios at 
the off-axis distance. The maximum SD was ± 0.01 (1 SD).  
Overall, the in-field correction increased with the increasing phantom thickness and off-
axis distance. For example, the difference in field area increased from 8.40% to 10.45% at an off-
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axis distance of 13 cm when the phantom thickness increased from 0 cm to 20 cm. Similarly, the 
difference in field area for a given phantom thickness increased from 0.95% to 10.45% at the off-
axis distances of 2 and 13 cm, respectively. Consequently, the magnitude of the required correction 
will increase with an increase in phantom thickness or off-axis distance. 
 
 
Figure 4.9: Difference in-field area derived from the ratio of the ionization chamber to EPID responses for 
a given phantom thickness, for a field size of  20×20 cm2 at a SDD =150 cm using a photon energy of 6 MV and a 
dose rate of 600 MU/min. For some points, the error bars are the same size or smaller than the symbols used. 
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Figure 4.10: 2D in-field area correction matrixes for a given phantom thickness obtained from the ratio of 
the ionization chamber to EPID responses at a source-to-surface distance (SDD) =150 cm. In each correction matrix, 
the corrections were extended to cover the whole EPID panel (data fitting details are listed in appendix A.3). 
Figure 4.11 shows the verification of the in-field area correction by comparing EPID and 
dose profiles for a range of field sizes and phantom thickness and the 1D gamma pass rates (3%, 
3mm criteria, all dose value included) in tables reported from Table 4.1 to Table 4.5. Gamma pass 
rates were reported for the in-field area and total field (in-field area and out-of-field area). The 
EPID and ionization chamber (CC13 in the water phantom) results in the in-field region showed 
excellent agreement, with the mean for the total gamma pass rate for the profiles examined of 
94.15 ± 5.2 % (1SD), with a maximum and a minimum pass rate of 100% and 90%, respectively. 
One outlier was observed for the total gamma pass rates for a field size of 15×15 cm2 with a given 
phantom thickness; the gamma pass rate for the total field was a mean of the pass rate, at 76.86% 
± 3.8%. (1SD). 
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Figure 4.11: Comparison of the relative dose on the central axis in the cross-plane direction measured by 
the ionization chamber (red color) versus the EPID before (blue color) and after (green color) application of the in-
field area correction for delivery of various field sizes ranging from 5×5 to 20×20 cm2 using a photon energy of 6 
MV, a dose rate of 600 MU/min, and different phantom thicknesses.  
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Table 4.1: 1D gamma pass rates (3%3mm criteria) reported for total and in-field area between the cross 
profiles of ionization chamber and EPID; phantom thickness was 0 cm. 
 
 
 
 
 
 
Table 4.2: 1D gamma pass rates (3%3mm criteria) reported for total and in-field area between the cross 
profiles of ionization chamber and EPID; phantom thickness was 5 cm. 
 
 
 
 
Field size (cm2) Before correction (%) After correction (%) 
Total In field Total In field 
5 100 100 100 100 
10 80.27 70.96 90 100 
15 57.97 54.52 78.53 100 
20 42.77 43.67 92.46 100 
Field size (cm2) Before correction (%) After correction (%) 
Total In field Total In field 
5 100 100 100 100 
10 86.04 73.62 92.9 100 
15 64.98 53.73 81.93 100 
20 42.62 37.97 92.72 100 
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Table 4.3: 1D gamma pass rates (3%3mm criteria) reported for total and in-field area between the cross 
profiles of ionization chamber and EPID; phantom thickness was 10 cm. 
 
 
 
 
 
 
Table 4.4: 1D gamma pass rates (3%3mm criteria) reported for total and in-field area between the cross 
profiles of ionization chamber and EPID; phantom thickness was 15 cm. 
Field size (cm2) Before correction (%) After correction (%) 
Total In field Total In field 
5 100 100 100 100 
10 87.73 72.73 96.24 100 
15 65.66 53.97 77.31 100 
20 41.05 40.87 92.66 100 
Field size (cm2) Before correction (%) After correction (%) 
Total In field Total In field 
5 100 100 100 100 
10 86.01 69.57 96.24 100 
15 64.98 51.51 74.65 100 
20 40.49 37.97 92.75 100 
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Table 4.5: 1D gamma pass rates (3%3mm criteria) reported for total and in-field area between the cross 
profiles of ionization chamber and EPID; phantom thickness was 20 cm. 
 
 
 
 
 
 
4.3.2.3 Out-of-Field Area Correction  
After applying the in-field area correction, it was noticed that the differences remained 
between the reference and EPID profiles in the out-of-field region. Figure 4.12 shows the 
calculated differences at the out-of-field area for a range of field sizes and phantom thicknesses. 
Data were fitted using a nonlinear regression fit, second order polynomial quadratic method 
(details for the fitting parameters are given in appendix A.4). The differences were strongly 
dependent on the field size and were highest for the largest field size. The maximum difference 
was approximately 0.68 (5.8%) for a field size of 20×20 cm2. The difference appeared independent 
of the phantom thickness, as the difference based on changes in phantom thickness was 
approximately 0.01.		
	
Field size (cm2) Before correction (%) After correction (%) 
Total In field Total In field 
5 100 100 100 100 
10 86.01 69.57 96.24 100 
15 64.46 54.04 71.9 100 
20 41.44 38.34 92.78 100 
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Figure 4.12: Differences in the out-of-field area normalized to the beam central axis obtained from EPID 
and ionization chamber measurements for a range of field sizes and phantom thicknesses at a source-to-surface 
distance (SDD) =150 cm and using a photon energy of 6 MV and a dose rate 600 MU/min. The values are shown as 
data points. The dashed lines represent the fit to the data points. 
 Figure 4.13 shows the verification of the out-of-field area correction by comparing EPID 
and dose profiles measured by an ionization chamber (CC13) scanned in water for a range of field 
sizes and phantom thickness and reporting 1D gamma pass rates (3%3mm criteria, all dose value 
included) in Table 4.6 to  Table 4.10 . The gamma pass rates were reported for the out-of-field and 
total field (in-field and out-of-field) areas. Overall, the EPID came to agree with the ionization 
chamber profiles for the total field. The mean of the total gamma pass rate after applying the 
correction for the profiles was 99.45 ± 0.5, with a maximum of 100% and a minimum of 98.31%. 
For the out-of-field area, the mean gamma pass rate was 98.46%.  
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Figure 4.13: Comparison of the relative dose on the central axis in the cross-plane direction measured by 
ionization chamber (red color) and EPID before (blue color) and after (green color) application of out-of-field area 
correction for delivery of various field sizes ranging from 5×5 to 20×20 cm2 using a photon energy of 6 MV and a 
dose rate of 600 MU/min for a 20 cm slab phantom in the beam direction. 
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Table 4.6: 1D gamma pass rates (3%3mm criteria) reported for total and out-of-field areas between the 
cross profiles of ionization chamber and EPID; phantom thickness was 0 cm. 
 
 
 
 
 
Table 4.7: 1D gamma pass rates (3%3mm criteria) reported for total and out-of-field areas between the 
cross profiles of ionization chamber and EPID; phantom thickness was 5 cm. 
 
 
 
 
 
 
Field size(cm2) Before correction (%) After correction (%) 
Total Out field Total Out field 
5 100 100 100 100 
10 80.27 87.9 99.26 98.66 
15 57.97 65.1 98.31 100 
20 42.77 35.11 100 100 
Field size(cm2) Before correction (%) After correction (%) 
Total Out field Total Out field 
5 100 100 100 100 
10 86.04 96.18 99.38 98.87 
15 62.44 80.47 100 100 
20 42.62 42.49 99.38 94.05 
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Table 4.8: 1D gamma pass rates (3%3mm criteria) reported for total and out-of-field areas between the 
cross profiles of ionization chamber and EPID; phantom thickness was 10 cm. 
 
 
 
 
 
Table 4.9: 1D gamma pass rates (3%3mm criteria) reported for total and out-of-field areas between the 
cross profiles of ionization chamber and EPID; phantom thickness was 15 cm. 
 
 
 
 
 
 
 
Field size(cm2) Before correction After correction (%) 
Total Out field Total Out field 
5 100 100 99.44 99.27 
10 87.73 99.95 100 100 
15 65.66 89.76 99.2 97.55 
20 41.05 42.61 99.76 97.73 
Field size(cm2) Before correction After correction (%) 
Total Out field Total Out field 
5 100 100 100 100 
10 86.01 99.52 99.08 98.33 
15 64.98 92.91 99.2 97.55 
20 40.49 62.29 99.11 91.43 
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Table 4.10: 1D gamma pass rates (3%3mm criteria) reported for total and out-of-field areas between the 
cross profiles of ionization chamber and EPID; phantom thickness was 20 cm. 
 
 
 
 
4.3.2.4 Absolute Dose Calibration Factor 
The dose measured by the ionization chamber at 150 cm SDD for delivering 100 MU using a 
field size 10×10 cm2 and 6 MV was equal to 44.44 cGy at the depth of the dose maximum. The 
absolute calibration factor required to convert the EPID measurement from an intensity value to a 
dose value was equal to 8.3e-05 cGy−1. 
4.3.3 Validation of EPID-based Transit Dosimetry  
Table 4.11 shows the gamma pass rate results using a criterion of 3%/3mm for comparison 
between EPID and MapCHECK transit dose planes at 150 cm SDD for thirty dIMRT fields (three 
H&N and two prostate). For all the dIMRT test fields, the mean gamma pass rate was 94% ± 3, 
with a maximum and minimum of 99.7% and 86.7%, respectively. The mean gamma pass rate for 
each treatment site was similar, at 94% ± 3.7(1SD) and 93.6% ± 3.9 (1SD) for H&N and prostate, 
respectively. An example of a gamma comparison is shown in Figure 4.14. 
Field size(cm2) Before correction (%) After correction (%)  
Total Out field Total Out field 
5 100 100 100 100 
10 86.5 99.52 99.5 98 
15 66.46 54.04 99.32 97.92 
20 41.44 68.29 100 100 
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Table 4.11: Numerical values representing gamma pass rates for dosimetric comparison between transit 
doses measured using the EPID and MapCHECK and a criterion of 3%3 mm for the in-field area. The fields listed 
are based on the treatment site; the mean and SD were reported for particular treatment sites. 
H&N Pass rate % Prostate Pass rate % 
F1 89.9 F1 89.8 
F2 96.1 F2 90.3 
F3 94.6 F3 89.4 
F4 95.8 F4 90.3 
F5 87.6 F5 94.9 
F6 90.4 F6 86.7 
F7 98.1 F7 91.1 
F8 98.7 F8 96.3 
F9 90 F9 97.4 
F10 99.7 F10 98.2 
F11 98.8 F11 94.7 
F12 96.3 F12 97.4 
F13 94.4 F13 9 
F14 91.6 F14 97.9 
F15 92.8 Mean     93.6% ± 3.9%(1SD) 
 F16 93.5 
Mean                   94% ± 3.7 %(1SD) 
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Figure 4.14: The dose measured by the EPID and MapCHECK for the head and neck (H&N) field (F10), a) 
Transit dose measured by EPID. b) Transit dose measured by MapCHECK. c) Comparison of the dose on the central 
axis in the cross-plane direction, d) Comparison of the dose on the central axis in the in-plane direction, g) Gamma 
image result using a criterion of 3%3 mm for the in-field area.   
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Figure 4.15 shows the examination of various gamma criteria to compare between a transit 
dose measured by the EPID against a dose measured by the MapCHECK. As expected, using the 
wider gamma criterion of 5%3mm yielded a higher gamma pass rate, with a mean gamma pass 
rate of 96.2% ± 3% (1SD). Similarly, using a criterion of 3%3mm, the mean gamma pass rate was 
93.96% ± 3.7% (1SD). The mean gamma pass rate for a criterion of 3%2mm, 2%3mm, and 
1%5mm were similar, at about 90.8 ± 4.6(1SD), 91.3 ± 4.5(1SD), and 88.3 ± 4.9% (1SD), 
respectively. Using a tighter gamma particle distance-to-agreement decreased the gamma pass 
rates. The lowest gamma pass rate was generated using a gamma criterion of 3%1mm and 2%2 
mm. For example, the gamma pass rate for field seventeen dropped from 93.4% using a criterion 
of 5%3 mm to 71.4% and 77.1% using a criterion of 3%1mm and 2%2 mm, respectively. The mean 
gamma pass rate for criterion of 3%1mm and 2%2 mm were 83.3% ± 5.1% (1SD) and 86.5% ± 
5.5% (1SD), respectively. 
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Figure 4.15: Percentage of gamma pass rates between the dose measured by the EPID versus MapCHECK 
for thirteen dIMRT fields using various gamma criteria. 
4.4 Discussion 
The goal of the measurement-based approach is to convert 2D transit EPID images to the 
equivalent 2D water dose distributions deposited in the detector plane at a depth of 1.5 cm. 
Comparison to the measurement-based approach of Sabet et al. [135] revealed that their approach 
required a number of corrections to calibrate the EPID image to a dose for the in-field area. These 
corrections included removing the FF clinical calibration, applying PSM to restore the horn effect, 
off axis correction, and a combination of field size and phantom thickness correction. The study 
presented in this chapter further develops this approach to remove the need for further processing 
with FF clinical calibration, and it calibrates the EPID response to a dose in the in-field area using 
a single correction (the in-field area correction). In addition, the advantage of this method over 
previous approaches is that it does not require the application of a kernel using a convolution or 
deconvolution process, or the use of MC simulation [74, 98, 110, 115, 116, 118]. An interesting 
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feature of this approach is that it is not dependent on TPS, and has no impact on treatment time. It 
requires a small set of corrections, including corrections for backscatter, the in-field area, the out-
of-field area, and an absolute dose calibration factor. Therefore, this method is relatively simple 
and easy for clinical implementation.  
4.4.1 External Build-up Thickness 
When no Cu sheet is placed on the EPID panel, the highest difference in response between 
the EPID and ionization chamber was observed at an air gap of 20 cm. This may be because the 
highest fraction of scatter from the patient is located in the lowest air gap [73]. When a Cu 
thickness of 1.65, 2, or 2.5 mm was added, the difference in response between the EPID and 
ionization chamber was reduced to within 1% for most of the air gaps examined. A Cu thickness 
of 1.65 was selected in this study as the external build-up material for delivery of a photon beam 
of 6 MV. Use of Cu with this thickness imposes less weight than the other examined thicknesses, 
so it is less likely to create an EPID positioning issue, particularly with rotation of the gantry.  
In previous studies, a Cu thickness of 2.2 to 3 mm was determined as an optimal build-up 
thickness (see Table 4.12), but the optimal thickness determined in this study was slightly less than 
this. This difference could have arisen from differences in thickness values used in previous work, 
which ranged from 1 to 5 mm and did not consider intermediate values such as 1.65 mm [135], 
These thicknesses were also suitable for a different range of energies, from 6 to 18 MV [74, 100]. 
The effect of external build-up material at the centre beam was investigated previously in a 
number of studies [63, 74, 135]. Our findings show the effect at the centre beam as well as at the 
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off-axis beam. Adding a Cu sheet to the EPID panel reduced the over-response of the EPID at the 
off-axis distance by 1.6%.  
Table 4.12: List of key references utilizing the extra Copper build-up material for EPID transit dosimetry 
applications. 
Cu thickness (mm) Photon energy 
(MV) 
Reference Type of EPID 
2.5  6,10,18 [100] Elekta, intrinsic, 1 mm Cu 
2.2  6  [135] Varian, intrinsic, 1 mm Cu 
3  6, 10  [74] Siemens, intrinsic, 1 mm aluminum 
No Cu  6,10  [126, 136, 180] Varian, intrinsic, 1 mm Cu 
 
4.4.2 Corrections to Convert the Transit EPID Image to a Transit Dose 
4.4.2.1 EPID Arm Backscatter Correction 
Our study validated the approach taken by Berry et al. [172] to remove the backscatter 
effect when it is applied for EPID transit dosimetry applications. After application of the arm 
backscatter correction, the comparison between the in-plane and cross-plane profiles for a number 
of field sizes showed good agreement, with slight random variations between them. These 
variations could be attributed to non-uniformity reported at the in-plane profile for cine images 
[56]. In addition, the age of the EPID panel could create some non-uniformity in the image. 
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Arm backscatter was quantified under a full scatter condition (20 phantoms on the treatment 
couch). The maximum percentage of correction required to remove backscatter from the arm was 
3%, which was comparable to the required correction of 3.6% reported by Berry et al. [172]. The 
slight difference could be due to the measurements being run in different SDDs, with existing 
phantoms. A change in SDD can reportedly affect the backscatter component by less than 1%  [83].  
Some researchers have reported requiring higher values of up to 6.5%  [71] and 14% [75] to 
remove backscatter. This could reflect differences in quantification of the backscatter by 
comparison between the arm on (normal operating condition) and extraction of the EPID panel 
from the arm (research condition). In addition, the previous researchers removed the FF calibration 
and used PSM, which may have affected the backscatter results. 
Our findings showed that the magnitude of the required correction depends on the field size, 
which may be a consequence of the FF calibration. The backscatter appears in both FF and raw 
images. When a raw image is divided by the FF image, the residual backscatter will depend on the 
field size. For example, if the delivered field size was small compared to the size of the field where 
the FF image was acquired (30×40 cm2), then the residual backscatter will be high. Conversely, if 
the delivered field size is comparable to an FF image (30×40 cm2), then the residual will be too 
small. 
4.4.2.2 In-Field Area Correction 
The EPID no-water-equivalent response particularly in the in-field area, arises from a 
number of factors but especially from the existence of the phosphor layer in the structure of the 
EPID and FF clinical calibration. The advantage of our novel in-field area correction is that it does 
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not deal with each factor individually. Instead, it combines the impact of these factors and designs 
a single correction to calibrate the EPID response to a dose in the water response for this area. This 
correction is quite straightforward to derive and could be easily applied into any EPID system. 
The difference between the EPID response and the ionization chamber measurement at the 
in-field area increases with increases in phantom thickness and off-axis distance. Consequently, 
the magnitude of the required correction increases with an increase in phantom thickness and off-
axis distance. To explain this, the FF clinical calibration makes the EPID profile flat in the absence 
of a phantom, while the dose profile has a horn effect. When the phantom is excited, the response 
of the dose profile and the EPID profile will be reduced at the off-axis distance due to filtering of 
the low energy photons, which typically are located at the off-axis distance. Even when both 
profiles are reduced, the EPID profile exhibits a stronger reduction compared to the dose profile 
due to the higher sensitivity of the EPID to this type of photon. 
The existence of a phantom in the clinical beam has two consequences: hardening of the 
beam and increasing the radiation scatter component. The findings in the present study support 
beam hardening as the dominant factor in the EPID response to changes in the phantom thickness. 
This finding confirmed previous results obtained by measurements [180] or MC simulation [181]. 
The verification of the in-field area correction gives a good agreement with the EPID versus 
the ionization chamber for all the examined profiles for all phantom thicknesses, excluding the 
profile for the field size of 15×15 cm2. This exception could reflect an experimental error in 
positioning the ionization chamber during the dose profiles scanned for this field size.  
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4.4.2.3 Out-Field Area Correction 
For the out-of-field region, Figure 4.12 shows that the EPID had a higher response in this 
area when compared to the ionization chamber, and its response mainly depended on the field size. 
This is because increases in the field size will increase the scatter and give an EPID over-response 
for the low energy, leading to a higher response in the tail when compared to the dose profile. This 
finding agrees with the out-of-field correction conducted by Sabet et al. [135], but contradicts the 
study by Nijsten et al.  [74] as it was found that the out-of-field region response did not depend on 
the phantom thickness.  
4.4.3 Validation of EPID-based Transit Dosimetry  
The aim of this study was to compare EPID dosimetry to a detector with a comparable 
resolution, such as radio-chromic film. However, the measured dIMRT fields in SDD at 150 cm 
using film were not sufficiently sensitive at this large distance. The MapCHECK is the available 
dosimetry in the center where the experiments are conducted. Some difference between the dose 
measured by EPID versus MapCHECK was expected, since EPID has a resolution of 0.784 cm, 
whereas MapCHECK has a resolution of 7 and 14 mm for the center and outer portions, 
respectively. 
The effect of different resolutions was determined by comparing the transit doses of the 
EPID versus MapCHECK using various gamma criteria. The expectation was that the gamma pass 
rate would be lower following a reduction in the gamma criteria regarding the tolerance of distance. 
This indicates a weakness of the MapCHECK due to its resolution. By contrast, if the gamma pass 
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rate was lower following a reduction in the gamma criteria regarding the tolerance of dose, this 
indicates a weakness of EPID dosimetry. 
Figure 4.15 shows the lower gamma pass rates obtained when using a tolerance of distance 
to agreement of 3%1mm and 2%2mm. This clearly supports our expectation, due to the differences 
between the resolution of the detectors. However, despite the resolution issue, good agreement 
was observed between the transit doses using EPID compared to MapCHECK using a clinical 
criterion of 3%3mm. The mean gamma pass rate was 94% ± 3.  
The worst case of agreement between the doses measured by EPID versus MapCHECK 
had a gamma pass rate of 86.7%. A closer examination of this case is shown in Figure 4.16. The 
reason for this failed comparison is clear from the cross-plan profiles. The maximum dose value 
for the EPID was 20.5 cGy, whereas the maximum dose for the MapCHECK was 17.3 cGy. 
Because the MapCHECK has a large discrete detector compared to the EPID, the region of 
maximum dose was not acquired by MapCHECK. In addition, the out-of-field area correction was 
underestimated when compared to the MapCHECK value. Upon checking all the comparison 
profiles, it was found that the underestimation of the EPID response corresponded with the 
radiation fields that were delivered by a large number of MU. This may indicate that an increase 
in the number of MU also increased the transmission beam through the MLC, and as this beam is 
commonly filtered, when it is turned on it reduces the response of the EPID. 
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Figure 4.16: Comparison of dose on the central axis in the cross-plane direction between the EPID and 
MapCHECK transit doses for deliver dIMRT field. 
4.4.4 Limitations 
The backscatter correction was made assuming symmetry in the profile, but asymmetry is 
sometimes reported in the clinical setting. Therefore, the value for symmetry reported in a 
monthly QA result for a linac was checked. This was less than 1% during the period of the study.  
A larger clinical field cannot be measured by EPID at 150 cm, as its imaging area is limited 
to 30×40 cm2. However, a recent model of linac is equipped with a larger imaging area (40×40 
cm2).  
For clinical applications, this approach requires a decision about the field size and phantom 
thickness. In the present study, the IMRT field size was chosen based on visualization of the EPID 
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image at an extended distance, such as 150 cm SDD, and then the field size at 100 cm SDD was 
estimated. Therefore, uncertainty could arise due to this process that depends on the decision of 
the user. Regarding patient thickness, the water equivalent thickness of the patient could be derived 
from CT images [135]. For the backscatter correction, some fields are small in size but located 
away from center, and since the backscatter effect depends on the pixel location, one has to use a 
large field size to cover whole area from the center of the imager to the delivered field.  
Two limitations also arise regarding the accuracy of the out-of-field corrections employed 
in this study First, these corrections were extracted using a field size defined by the jaw not by the 
MLCs. EPID profiles plotted for a field size defined by the jaw and MLCs are shown in Figure 
4.17. The differences appear at the out-of-field area, and the tail for the profile using MLC delivery 
is slightly smaller when compared to the profile delivered by the jaw. We have also used an 
ionization chamber to measure the dose at the penumbra region. The ion chamber measurements 
are the gold standard for clinical dosimetry, but the detector size of 0.13 cm3 compromises some 
degree of the special resolution, which is lower compared to the EPID resolution. In the out-field 
area, where the dose fall off is considerably high, a detector with high resolution, such as a diode, 
is recommended. Due to these limitations, the out-of-field region was excluded in the comparison 
of EPID to MapCHECK doses. 
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Figure 4.17: The difference between EPID profile when a field size is defined by the jaw and multi leaf 
collimator (MLC). 
4.5 Conclusion 
This study presents the development of a measurement-based method for 2D transit EPID 
dosimetry. The data show that the in-field area correction is dependent on the phantom thickness 
and the off-axis distance, whereas the out-of-field area correction depends on the field size. The 
advantage of this method is that it is less complicated than previous methods, it maintains the FF 
clinical calibration and uses only one correction to calibrate the EPID response to dose for the in-
field area. This method could be a promising tool for monitoring inter-fraction variations. 
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Chapter 
5 EPID based Transit Dosimetry to Monitor 
Inter-Fraction Patient Variations 
 
 
 
 
 
 
 
 
 
  
112 
 
5.1 Introduction 
A dose change of 5% has a clinically relevant impact as it alters the risk of morbidity or of 
impairment of the tumor response [182].Inter-fraction patient variations, particularly positional 
and anatomical variations, have been reported as a relevant type of radiotherapy error [17, 147, 
183]. One study conducted over a 10-year period showed that 40.4% of all the radiotherapy errors 
were caused by patient setup errors [184]. Shifting of the patient also had a high potential 
occurrence, based on 2599 reported incidents collected over a period of 2.5 years by the 
Department of Radiation Oncology at the University of Washington [17].  
Examples of dose differences caused by positional and anatomical variations have been 
reported. Discrepancies of 20% in dose have also been reported due to morphological changes 
[185]. A movement of the isocenter point by 1 cm was reported to yield a dose difference in organ 
at risk of up to 84.2% [186], and a patient shift of 10 mm can lead to a change in dose of 57% [90]. 
A couch location error of 3 mm can cause a 38% decrease in the minimal target dose or a 41% 
increase in the minimal spinal cord dose [187]. The change in tumor volume for H&N treatment 
site over all fractions was reported as between 1% to 11% [146]. 
The EPID has demonstrated its value in transit dosimetry [17] However, most of the 
available literature regarding EPID transit dosimetry during treatment has been devoted to 
reporting the proposed approaches [96, 115, 124] or relevant clinical expertise [157, 160, 161]. To 
date, limited studies have quantified the sensitivity of EPID dosimetry in detecting patient 
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variations, and these studies were restricted on the use of the common gamma criterion 3%/3 mm 
[90, 150]. 
The aims of this study were first to present a simple calibration method, introduced in 
Chapter Four, for use in EPID based transit dosimetry as a tool for detecting dose inconsistencies 
during treatment fractions, and specifically patient-related errors: patient position and anatomical 
changes. A second aim was to determine the sensitivity of EPID transit dosimetry for detecting 
patient variations using various gamma criteria. Variations that could not be detected by gamma 
analysis were examined using a structural similarity (SSIM) index. 
5.2 Method 
An a-Si-500 EPID fixed to a Varian linear accelerator 21iX (Varian Medical Systems, 
USA) was used. The EPID was irradiated with a photon energy of 6 MV at a dose rate of 600 and 
400 MU/min, at SDD 150 cm, and the gantry angle set to zero. The decision to use a constant 
gantry angle was made to prevent errors in measurement due to sagging of the EPID [50]. Images 
were acquired using the cine acquisition mode and the IAS3 software (version 8.2.03), and 
multiple cine images results from each delivery were summed to give one image. Cine images 
were acquired for 3DCRT as well as dIMRT, in multiple fractions. The transit images were then 
converted to doses, based on the method introduced in Chapter Four. In total, two hundred images 
were converted to doses. Raw transit EPID images were multiplied pixel by pixel with a 
backscatter correction matrix and the images were then multiplied pixel by pixel by an in-field 
area correction. The resulting images were then corrected by subtracting an out-of-field area 
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correction factor. Finally, the outcome images were multiplied by an absolute dose calibration 
factor (see Figure 4.2 in section 4.2.2).  
The transit dose images using EPID were acquired at the SDD of 150 cm. The transit dose 
image in the first fraction was considered as the reference dose. Variations in patient position or 
weight were then introduced in the subsequent fractions. The dose difference between the first and 
subsequent fractions was then computed using various gamma criteria and the SSIM index.  
In the present study, the magnitude of variations was chosen based on the previously 
reported data for which the magnitude of positional or anatomical variations could yield a 
clinically relevant impact. For position variations, the literature clearly indicates that a shift in 
patient position in the order of mm causes clinically relevant changes [90]. Therefore, in our study, 
we selected the minimum magnitudes of positional variations ranging from 2 to 5 mm. For 
anatomical variations, the literature contains no information regarding what magnitude of patient 
change in weight yields would have a clinically relevant impact, apart from a report indicating that 
changes up to 1 cm had a small clinical impact [90]. Therefore, we selected minimum magnitudes 
of anatomical variations ranging from 1 to 4 cm. 
5.2.1 Inter-Fraction Variations 
5.2.1.1 Positional Variations 
Positional variation was examined on two treatment sites using a head & neck phantom 
(Alderson RANDO, USA) and a stationary lung phantom (CIRS, USA). Figure 5.1 illustrates the 
position of each phantom on the couch treatment. The initial position of the phantom was selected 
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based on the dIMRT clinical plan for each treatment site. The position of the phantom was moved 
by 2, 3, 4, and 5 mm to the right of isocenter using the treatment couch digital position indicators. 
Clinically approved, previously delivered dIMRT and 3DCRT plans were selected for this 
study. The variation in fields (e.g., MU, size of field) was considered when the delivered fields 
were selected. For the H&N treatment site, eight fields were delivered: four 3DCRT and four 
clinical dIMRT of the head and neck. Similarly, for the lung treatment site, eight fields were 
delivered, comprising four 3DCRT and four clinical dIMRT of the lung. A total of eighty EPID 
transit images were acquired.  
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Figure 5.1: The phantom and setup of the experiment related to position variation. The phantom was 
positioned at SSD 90 cm (the distance from source to couch was 110 cm) to simulate the position variations 
measuring by the EPID, the EPID was positioned at 150 cm. The external build up was added on EPID panel, which 
was decided in Chapter Four (Copper thickness of 1.65 mm), a) Head & Neck phantom. b) Lung phantom. 
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5.2.1.2 Anatomical Variations 
The patient weight changes were examined using a slab phantom with three different 
scenarios: solid water that simulated tissue, medium-density fiberboard (MDF) that simulated fat, 
and Styrofoam that simulated the lung. The phantom scenarios, with details, are listed in Table 
5.1. 
The initial thickness of the phantom in all scenarios consisted of 20 sheets, each 1cm in 
thickness (see Figure 5.2). Variations were introduced by removing 1, 2, 3, or 4 sheets of the 
material of interest in each scenario. Anatomical variations were studied using eight fields, four 
3DCRT, and four clinical dIMRT. The total number of EPID transit images acquired was one 
hundred and twenty.  
Sheets of each material were scanned using CT (Philips Brilliance CT scanner, USA) with 
a photon energy of 140 KV to quantify the density of the material as a CT number, expressed in 
Hounsfield units (HU). The CT number is defined as the linear attenuation coefficient µ of a 
material at a given kVp and the attenuation coefficient of water at the same kVp:  
   CT	number	 = 	1000	 ×	 (E/EF*GH))EF*GH) 																		(2) 
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Table 5.1: The phantom scenarios to simulate anatomical changes in patient weight (e.g., reduced weight). 
 Scenario 1 Scenario 2 Scenario 3 
Phantom Homogeneous, 20 cm slabs of 
solid water. 
 
Heterogeneous, 5 slabs of MDF 
embedded in 15 cm of solid water. 
Heterogeneous, 5 slabs of 
Styrofoam embedded in 15 cm of 
solid water 
Shape 
   
Measured CT 
number (HU) 
0 
Mimics water, which is 
reported as about 0 [188] 
-200 
Mimics fat, which is reported as 
about -50 to -100 [188] 
-700 
 Mimics lung, which is reported as 
about -850 to -910 
 [188] 
Area of sheet 
(cm2) 
30×30 30×30 30×30 
Thickness of slab 
(cm) 
1  1 1 
Manufacture PTW, Freiburg,Germany 
 
PLYCO Pty Ltd, Melbourne, 
Australia 
PLYCO Pty Ltd, Melbourne, 
Australia 
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Figure 5.2: The slab phantom and setup of the experiment related to anatomical variations. The phantom 
was positioned at SSD of 90 cm (the distance from source to couch was 110 cm), the EPID was positioned at 150 
cm. The external buildup was added to the EPID panel, as determined in Chapter Four (thickness of 1.65 mm). 
5.2.2 Image processing 
Cine images were exported from IAS in DICOM (dcm) format, then images were imported 
to MATLAB (VR2012 b). To convert transit images to doses, images were processed using an in-
house code written in MATLAB and run in a double class file. Transit dose images in the 
MATLAB were converted again to a dcm file. 
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5.2.2.1 Data Analysis 
EPID transit dose images (reference and with variations) were imported to SNC Patient 
software (Sun Nuclear Corporation, United States) to run a gamma analysis. The gamma analysis 
was run as an absolute dose rather than a relative dose, and a criterion of 3%/3 mm using a global 
gamma analysis with a 10% threshold was adopted because this is typically used in clinical settings 
and is the most common clinical acceptance criterion [176]. A gamma analysis with a criterion of 
3%/3 mm was applied using local gamma analysis, where the percentage dose difference is 
calculated relative to the dose at each point in the measurement field. Although 3%/3 mm is the 
most common criterion, it has a low sensitivity for detecting errors for pre-treatment verification 
[176]. Therefore, additional criteria of 3%/2 mm, 3%/1 mm, 2%/3 mm, 2%/2 mm, 2%/1 mm, and 
1%/1 mm were applied for global gamma analysis. 
The gamma pass rates varied widely among multi-institutional studies [189]. A gamma 
pass rate of 95% was adopted in some studies when the gamma analysis compared two different 
dosimetry systems; for example, TPS vs. EPID. This selection was made because of the mismatch 
between the two dosimetry systems, such as the uncertainty for each one. In our study, we 
compared dose image results from similar dosimetry systems, so no mismatch existed between the 
dosimetry systems. We decided on the detection level by having the dIMRT delivered three times 
at an interval of two months. The results for gamma analysis between these doses was greater than 
98%. This could be due to the uncertainty of the beam delivery parameters, such as daily linac 
output variations and the localizing laser coincidence with the isocenter. The monthly and daily 
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QA results were within acceptable tolerance over the period during which the measurement 
performed, but some uncertainty relating to this still remained. Another explanation could involve 
the reproducibility of the EPID or the uncertainty of the software used for gamma analysis. 
Therefore, an assumption was made to use a 98% pass rate as a detection level. 
5.2.2.2 Structural Similarity Index 
Where the EPID cannot detect specific magnitude of variations using a gamma analysis 
with a criterion of 3%/3 mm, the SSIM index was used to compare the reference and dose variation 
images. SSIM index, which is a method for measuring the similarity between two images [190], 
evaluates a test image X with respect to a reference image Y to quantify their visual similarity. 
This approach has been used in radiological images, such as magnetic resonance imaging [190-
192]. The SSIM index is defined as a product of three comparison elements: luminance (L), 
contrast (c), and structural image quality (s), and described by the following equation [193]: 
II!J(K,L) = [N(K,L)]P. [R(K,L)]S. [T(K,L)]U         (3) 
where α > 0, β > 0, and Υ > 0 are parameters used to adjust the relative importance of three 
elements. The SIMM index was calculated between the reference and variation dose images using 
MATLAB (VR2016 b). The default setting of ‘one’ in MATLAB was used for these parameters.  
The SSIM index is a decimal value from 1 (high similarity) or lower. The publications 
about the SSIM index and its application express doubt regarding the minimum value. In the 
original publication about the SSIM index, published in 2004 [193] the author pointed out that the 
maximum value is 1 and did not discuss a minimum value; the paper also mentioned that the third 
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term in the equation (s) can be negative. In a subsequent publication [194] the author stated that 
the metric guarantees boundness, in the sense that −1 ≤ SSIM(x, y) ≤ 1. In most cases, however, a 
score is given for the interval [0,1], where values closer to 0 represent lower levels of image 
quality, while values nearer to 1 are indicative of higher levels of visual quality. Overall, to resolve 
the doubt in the minimum value, the SSIM index provides a decimal value from 1 (high similarity) 
and lower (if there is dissimilarity). This means that if a comparison between reference and dose 
variations gives a value of one, the EPID cannot detect a variation. By contrast, if the comparison 
yields a value less than one, this means that the EPID can detect the variations.  
5.3 Results 
5.3.1 EPID based Transit Dosimetry as a Tool to Detect Patient Variations 
In total, two hundred EPID images were converted to doses. An example of the graphical 
output is shown in Figure 5.3. The graphical output shows the dose image in the first fraction 
(reference dose), as well as the dose image in a subsequent fraction; both are represented in units 
of cGy. The gamma analysis image, with the numerical details associated with the dose profile 
comparison, is also presented. 
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Figure 5.3: Example of an EPID transit dosimetry system to monitor inter-fraction variations for a dIMRT 
field with an introduced the positional variation of 4 mm. The scale is the absolute dose value, which is given in 
terms of cGy. In the upper left: the transit dose in the first fraction (references dose); in the upper right: the transit 
dose in the subsequent fraction with an introduced positional variation; in the lower left: gamma analysis images 
using a criterion of 3%/3 mm; in the lower right: dose profiles that can be visualized based on the area of interest, 
which is selected by the user. The left column shows the numerical analysis and analysis setting (gamma analysis). 
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5.3.2 Sensitivity of EPID using Gamma Analysis 
5.3.2.1 Positional Variation 
5.3.2.1.1 Gamma A criterion of 3%/3 mm 
Figure 5.4 illustrates the average of the gamma pass rates using a criterion of 3%/3 mm for 
the delivered 3DCRT and dIMRT fields for each treatment site (H&N and Lung). The error bars 
represent the standard deviations after averaging the gamma pass rates of all fields.  
With a criterion of 3%/3 mm, an EPID cannot detect a positional variation of 2 and 3 mm 
for both treatment sites. For these magnitudes of variation, the gamma pass rates were similar for 
both treatment sites. The pass rates of 2 mm were 99.90% ± 0.04% (1SD) and 99.90% ± 0.05% 
(1SD) for H&N and lung treatment sites, respectively. Increasing the magnitude of variation up to 
4 mm enabled the EPID to detect the positional variation, and the pass rate was 97.70% ± 2.6% 
(1SD) for the H&N site, and 97.20% ± 2.9% (1SD) for the lung site. 
In addition, the sensitivity the EPID depended on the treatment site. With a magnitude of 
positional variations of 3, 4, and 5 mm, the EPID showed a slightly higher sensitivity for the lung 
treatment site than for the H&N treatment site. The maximum sensitivity for the lung treatment 
site was noted at a large magnitude of positional variation (5 mm). The gamma pass rates were 
92.19% ± 3% (1SD) for the lung treatment site compared to 97.70% ± 1.46% (1SD) for the H&N 
site. 
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Figure 5.4: Average gamma pass rates for 3DCRT and dIMRT delivered fields with a criterion of 3%/3 mm 
for a particular treatment site (Head & Neck (H&N) and Lung) when positional variations were introduced to the 
phantom. Error bars represent the standard deviation of the gamma pass rates of the fields. 
The sensitivity of the EPID based on the type of delivery technique (either 3DCRT or 
dIMRT field) is demonstrated in Figure 5.5. With a criterion of 3%/3 mm, the EPID cannot detect 
a magnitude of variations up to 3 mm, and the minimum positional variation it could detect was 4 
mm. Interestingly, the EPID exhibited a higher sensitivity for 3DCRT fields than for dIMRT fields. 
For example, the gamma pass rates for a positional variation of 4 mm was 97% ± 3.20% (1SD) for 
a 3DCRT field, while the gamma pass rate was 97.9% ± 2.05% (1SD) for dIMRT. The sensitivity 
of the EPID, based on the type of field, increased with an increase in the magnitude of variation. 
For a positional variation of 5 mm, the gamma pass rates were 93.97% ± 5.12% (1SD) for the 
3DCRT field, while it was 95.9% ± 4.05% (1SD) for the dIMRT. 
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Figure 5.5: Average gamma pass rates for 3DCRT and dIMRT delivered fields with a criterion of  3%/3 
mm when positional variations were introduced to the phantom. Error bars represent the standard deviation of the 
gamma pass rates of the fields. 
5.3.2.1.2 Global vs Local Gamma Analysis using A criterion of 3%/3 mm 
Figure 5.6 shows the sensitivity of EPID to detect positional variations as a function of 
global and local gamma using a criterion of 3%/3 mm. For both treatment sites, the EPID cannot 
detect positional variations of 2 and 3 mm by either global or local gamma analysis. Moreover, for 
these magnitudes of variations, both global and local gamma analysis provided similar pass rates. 
For example, with a positional variation of 3 mm for the H&N treatment site, the gamma pass rate 
was 99.7%± 0.14% (1SD) and 99.5% ± 0.30 (1SD) using global and local analysis, respectively. 
As the magnitude of variations increased, the sensitivity of the EPID was higher when using local 
gamma criteria than global gamma criteria for both treatment sites. For instance, for the lung 
treatment site with a positional variation of 5 mm had a gamma pass rate of 92.19% ± 3% (1SD) 
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and 90.04% ± 6.39% (1SD) using the global and local gamma criteria, respectively. However, a 
significant drop in the gamma pass rate was observed for a positional variation of 4 mm for the 
H&N treatment site when local gamma analysis was applied. The gamma pass rate declined by 
9%. 
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Figure 5.6: Average gamma pass rates for delivered fields with a criterion of 3%/3 mm using global and 
local gamma assessment when positional variations were introduced to the phantom. Error bars represent the 
standard deviation of the gamma pass rates of the fields. a) Head and neck (H&N) treatment site. b) Lung treatment 
site. 
129 
 
5.3.2.1.3 Gamma Analysis using Various Criteria 
When using a criterion of 3%/3 mm, the EPID shows insensitivity for a minimum 
positional variation (2 mm); therefore, subsequent analyses focused on using different criteria. The 
sensitivity of the EPID to detect positional variations when the gamma criteria changed from 
relaxed to tighter criteria for the H&N and lung treatment sites is illustrated in Figure 5.7. The 
results were obtained by varying the gamma criterion; 3%/3 mm, 3%/2 mm, 3%/1 mm, 2%/3 mm, 
2%/2 mm, 2%/1 mm, and 1%/1 mm. 
Overall, the results for both treatment sites demonstrated that the gamma pass rates were 
more dependent on a tolerance of the distance to an agreement than on a tolerance of the dose 
difference. In other words, the gamma pass rates were reduced with reduction in the tolerance of 
distance to an agreement. A criterion of 3%/3mm and 2%/2mm yielded pass rates higher than a 
criterion of 3%/2mm. The lowest gamma pass rates corresponded to the lowest distance tolerance 
(1mm), which were 3%/1mm, 2%/1mm, and 1%/1mm. 
For the H&N treatment site, that EPID was able to detect a positional variation of 2 mm 
when the tightest criterion of 1%/1 mm was applied. The gamma pass rate of the EPID was 
94.45%, whereas with others criteria, the pass rates were more than 98%. With an increased 
magnitude of the positional variation up to 3 mm, the EPID could detect this magnitude when the 
tolerance of the distance to agreement was 1 mm. The pass rates were 94.37%, 89.9%, and 82.13% 
for gamma criteria of 3%/1 mm, 2%1 mm, and 1%/1 mm, respectively. With an increased 
positional variation, up to 4 and 5 mm, these magnitudes of variation were detectible with 
relaxation and tighter criteria. Unexpectedly, the lowest pass rate was associated with the 
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magnitude of 4 mm, not with 5 mm. The lowest pass rate was 58.4%. For the lung treatment site, 
the EPID showed the ability to detect a slightly higher sensitivity with a 2 mm variation when 
compared to the H&N treatment site. It could be detected with a distance tolerance of 1 mm. The 
pass rates were 95.88%, 91.58%, and 80.98% for gamma criteria of 3%/1 mm, 2%/1 mm, and 
1%/1 mm, respectively. The lowest gamma pass rate was associated with the largest magnitude of 
positional variation and the tightest criteria: it was 54.78% for a variation of 5 mm with a criterion 
of 1%/1 mm. 
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Figure 5.7: Average gamma pass rates for all fields using gamma criteria of 3%/3 mm, 3%2 mm, 3%/1 
mm, 2%/3 mm, 2%/2 mm, 2%/1 mm, and 1%/1 mm for positional variation in a) Head and neck treatment site. b) 
lung treatment site. 
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5.3.2.2 Anatomical Variations 
5.3.2.2.1 Gamma A criterion of 3%/3 mm 
Figure 5.8 shows the gamma pass rates using a criterion of 3%/3 mm for the anatomical 
variations in three scenarios: a homogeneous slab phantom using solid water to mimic tissue 
variations, a heterogeneous slab phantom using MDF embedded in solid water to mimic fat 
variations, and a heterogeneous slab phantom using Styrofoam embedded in solid water to mimic 
lung variations. In each scenario, the 3DCRT and dIMRT fields were delivered. The error bars 
represent the standard deviation for the averages of gamma pass rates for each type of field. 
Overall, the results indicated that the EPID has a different sensitivity based on 
heterogeneities and the type of delivered field. It was more sensitive for tissue and fat variations 
than for lung variations. In addition, it was more sensitive for 3DCRT than for dIMRT.  
For tissue and fat variations, the EPID is highly sensitive for detection of a 1 cm change 
for 3DCRT fields, with pass rates of 68.13% ± 9.65% (1SD) and 91.02% ± 8.00% (1SD) for tissue 
and fat variations, respectively. With dIMRT, the minimum anatomical variation detectible by the 
EPID is 2 cm. The pass rates for a 2 cm variation were 79.77% ±11.75% (1SD) for tissue variation 
and 90.3% ± 8.49% (1SD) for fat variation. The sensitivity of the dIMRT fields increased with 
increasing magnitude of the variations, whereas for 3DCRT the sensitivity seemed to remain 
constant with increases in the magnitude of variation from 2 to 4 cm. By contrast, the EPID was 
insensitive for detection of lung variations up to 4 cm. The gamma pass rates were 100% for both 
types of fields. 
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Figure 5.8: Averaging gamma pass rates for 3DCRT and dIMRT delivered fields with a criterion of 3%/3 
mm for a particular material of interest when anatomical variations were introduced to the phantom. Error bars 
represent the standard deviation of the gamma pass rates of the fields. 
5.3.2.2.2 Global vs. Local Gamma Analysis using a criterion of 3%/3 mm 
 Figure 5.9 shows the effect of global and local gamma analysis with a criterion of 3%/3 
mm on the sensitivity of the EPID to detect anatomical variations. In general, the results show that 
the EPID has a slightly higher sensitivity to detect tissue and fat variations with local than with 
global gamma analyses. For instance, with a variation in the tissue of 1 cm, the gamma pass rates 
were 83.9% ± 11.75%(1SD) and 80.63% ± 11.75%(1SD) using global and local gamma analyses, 
respectively. Similarly, with a fat variation of 1 cm, the gamma pass rates were 94.82% ± 11.87% 
(1SD) and 93.52%  ± 12.10% (1SD) using global and local gamma analysis, respectively. In 
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contrast to the lung variations, the EPID could not detect these types of variations by either global 
or local gamma assessment. 
 
 
Figure 5.9: Average gamma pass rates for all fields (3DCRT and dIMRT) with a criterion of 3%/3 mm 
using global and local gamma assessment, when anatomical variations were introduced to a phantom. Error bars 
represent the standard deviation of the gamma pass rates of the fields. 
5.3.2.2.3 Gamma Analysis using Various Criteria  
Figure 5.10 illustrates the effect of changing gamma criteria from relaxed to tight on the 
sensitivity of the EPID to detect anatomical variations. For tissue and fat variations, the gamma 
pass rates using various criteria showed similar trends, with a higher sensitivity to detect tissue 
variations than fat variations. As expected, the gamma pass rates were reduced when using tighter 
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criteria and increasing the magnitude of the variations. The lowest gamma pass rate was linked 
with the use of the tightest criterion of 1%/1 mm and large variations (4 cm). The gamma pass 
rates were19.50% and 25.43% for tissue and fat variations, respectively. 
Interestingly, a similar to trend was noticed for positional variations, as the gamma pass 
rates were more dependent on the distance tolerance than on the dose tolerance. The higher pass 
rates were linked to the higher distance tolerance. Gamma criteria of 3%/3 mm and 2%/3 mm 
provided high gamma pass rates in most cases. For example, when 2 cm tissue variations were 
introduced, the gamma pass rates were 66.99% ± 12.25% (1SD) and 65.7% ± 12.21% (1SD) using 
3%/3 mm and 2%/3 mm, respectively. A further reduction in the distance tolerance (2 mm) gave 
gamma pass rates of 57.77% ± 9.04% (1SD) and 57.74% ± 7.87% (1SD) using 3%/2 mm and 2%/2 
mm, respectively. 
For lung variations, the EPID could only detect this type of variation using gamma criteria 
of 1%/1 mm. For an introduced 1 cm lung variation, the gamma pass rate was 92%. Outlier appears 
in a 2 cm variation with 1%/1 mm, with a gamma pass rate of 99.10%± 1.40% (1SD). The lowest 
gamma pass rates where noted with the largest lung variations (4 cm), at 70.07%. 
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Figure 5.10: Average gamma pass rates for all fields using gamma criteria of 3%/3 mm, 3%2 mm, 3%/1 
mm 2%/3 mm, 2%/2 mm, 2%/1 mm, and 1%/1 mm for anatomical variations introduced to a phantom,. a) tissue 
variation, b) fat variation, c) lung variation. 
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5.3.3 Sensitivity of the EPID using the Structural Similarity Index 
The EPID sensitivity with gamma analysis using a criterion of 3%/3 mm cannot detect 
small positional variations of 2 mm and 3 mm, and lung variations up to 4 cm. Therefore, the SSIM 
index was used instead of gamma analysis to compare between the reference dose image (first 
fraction) and the dose image with variations. The EPID transit dose images were analyzed using 
the SSIM index.  
Figure 5.11 shows the sensitivity of the EPID using the SSIM index to detect positional 
variations for delivered 3DCRT and dIMRT fields for each treatment site (H&N and Lung). Error 
bars represent the standard deviations for the average SSIM index for delivered fields.  The EPID 
could detect a small positional variation of 2 mm for SSIM of 0.92 ± 0.01 (1SD) and 0.95 ± 0.02 
(1SD) for the H&N and lung sites, respectively. In contrast to gamma analysis, the EPID using 
SSIM showed a higher sensitivity for the H&N treatment site than for the lung site. 
The SSIM index reduction with increased magnitude of the positional variation was slight, 
especially for the lung site. For the H&N treatment site, the variation in SSIM for 2 mm to 5 mm 
were 0.92 ± 0.01 (1SD) and 0.88 ± 0.03 (1SD), respectively. The lowest SSIM index was 
associated with a positional variation of 4 mm; it was 0.86 ± 0.01 (1SD). For the lung treatment 
site, the variation in SSIM range for 2 mm and 5 mm were 0.95 ± 0.02 (1SD) and 0.928 ± 0.03 
(1SD). The lowest SSIM index was associated with the largest positional variations. 
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Figure 5.11: Structural similarity index, which measures the similarity between the reference dose image 
and the dose image with positional variations for head and neck (H&N) and lung treatment sites. Error bars 
represent the standard deviations resulting from averaging the structural similarity indexes for fields.  
Figure 5.12 shows the SSIM index results for anatomical variations (lung). The error bars 
represent the standard deviation of the SSIM index resulting from averaging the fields. For 
anatomical variations (lung), the EPID could detect minimal lung variations (1 cm), with SSIM 
indexes of 0.97 ± 0.001(1SD) obtained for 3DCRT and 0.94 ± 0.01(1SD) for dIMRT fields; i.e., a 
higher sensitivity was observed for dIMRT than for 3DCRT fields. In addition, the reduction of 
the similarity index with an increased magnitude of variations was negligible.  
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Figure 5.12: Structural similarity index, which measures the similarity between the reference dose image 
and the dose image with anatomical variations (lung). Error bars represent the standard deviations resulting from 
averaging the structural similarity indexes for fields.  
 
5.4 Discussion 
5.4.1 EPID based Transit Dosimetry as A Tool to Detect Patient Variations 
The graphical output of this system in Figure 5.3 is shown to illustrate the power of 
comparing EPID transit doses as a tool to pick up patient variations. By using gamma analysis 
results and dose profiles, the user can identify and quantify the problematic areas of delivery in a 
field, whether caused by positional variation or anatomical variation. For example, the positional 
variations can be observed as a shift in the dose profile compared to the reference dose profile. 
The anatomical variations (increases or decreases in patient weight) can be observed as an increase 
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or decrease in the dose profile compared the reference dose profile. However, this assumes that 
any machine-related error is monitored by pre-treatment verification and in vivo verification in the 
first fraction, to prevent a wrong determination for the source of variations. For example, an 
observed increase in the dose profile compared to the reference profile could be due to an increase 
in the monitor unit delivered. Similarly, the shift of a profile with variation compared to a reference 
profile could be explained by a MLC shift. 
The goal of the 2D EPID transit dosimetry system is not to achieve the highest possible 
accuracy in the dose distribution received by a patient, but to trace and quantify, quickly and 
simply, if a dose deviation occurs during the course of treatment. This tool is independent of the 
linac (e.g., machine-reported log files) and the TPS (e.g., calculated dose). This dosimetry system 
is based on the philosophy that the course of treatment after the first fraction can be monitored by 
the EPID, rather than using a complex approach in each fraction (e.g., MC simulation, application 
of a kernel). This helps to direct the time and resources during patient treatments. 
At the time of this study, the PerFRACTION™ EPID software was under clinical 
evaluation. The main difference between our system and PerFRACTION™ is that the 
PerFRACTION™ system compares the EPID image in the first fraction to the EPID image in the 
following fractions, without converting the image to a dose. This means that no dose information 
is provided by the PerFRACTION™ comparison. 
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5.4.2 Sensitivity of EPID using Gamma Analysis with a criterion of 3%/3 mm 
We have examined the sensitivity of EPID transit dosimetry to detect clinically relevant 
patient variations based on our calibration approach described in a previous chapter, but we believe 
that the results of sensitivity of the EPID reported in the present study are characteristic of any 
EPID-based system and are not specific to the calibration procedure.  
Interestingly, for both types of variation (position and anatomic), the EPID has a higher 
sensitivity for 3DCRT than for dIMRT. This is associated with the uniformity of 3DCRT compared 
to the non-uniformity of dIMRT, and gamma analysis normalized the points to a maximum dose. 
Investigation of the beam profiles showed a flat profile for 3DCRD, and most points in the field 
area were similar to the maximum dose. Application of gamma analysis gave all these points 
similar passing or failing criteria. By contrast, with dIMRT, considerable variation was 
encountered in the dose profile across the field area, so the application of gamma analysis yields 
some points with passing and others with failing criteria.  
Positional variations using gamma evaluation confirmed that the EPID has a slightly higher 
sensitivity for lung than for H&N treatment sites. One explanation might be that the H&N site 
consists mainly of bony structures, whereas the lung phantom consists mainly of air cavity 
structures. A shift in an air cavity will change the transmission dose to a much larger extent than 
it will  shift in a bony structure [150]. In addition, the study presented in this chapter shows the 
weaknesses of a criterion of 3%/3 mm for detecting a small positional variation (2 mm). This is 
reasonable because the tolerance of distance to agreement is 3 mm; hence, the EPID cannot detect 
less than this value. The findings in this study further support the growing body of evidence that 
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suggests 3%/3 mm is too broad to detect clinically significant errors. Furthermore, using 3%/3 
mm, the minimum detectable positional variations using EPID is ≥ 4 mm for H&N and lung 
treatment sites. To date, no consistent values have been established for the minimum detectable 
positional variations using the EPID. Our finding (4 mm) was smaller than that previous reported. 
Hsieh et al.[150] found that a 5 mm positional variation cannot be detected using EPID 
PerFRACTION TM dosimetry for a H&N treatment site. This difference between our study and 
their study could reflect the selection of the gamma pass detection level, which was 95%. Bojechko 
et al.[90] reported that positional variation up to 10 mm cannot be detected by the EPID. No reason 
for the weakness of EPID detectability was identified in their study.  
With anatomical variations (e.g., weight loss) using gamma evaluation, the EPID can detect 
tissue and fat variations and exhibits higher sensitivity for tissue compared to fat variations. This 
is related to the attenuation factor: a denser material attenuates more X-rays. Therefore, tissue is 
more readily detected by the EPID when compared to the fat. Conversely, the EPID cannot detect 
lung variations up to 4 cm. Since the attenuation caused by the lung is insignificant, this was 
confirmed by performing similar measurements using an ionization chamber. The dose difference 
assessing by the ionization chamber was 1.1% when a lung variation of 4 cm was introduced. The 
EPID with the selection of a dose difference criterion of 3% was not able to detect a 4 cm lung 
variation, and a dose difference criterion of 1% is required to detect a 4 cm lung variation. 
For tissue and fat variations, as shown in Figure 5.8, the gamma pass rate for the 3DCRT 
field seemed to be constant even as the magnitude of variations increased. This could be caused 
by the gamma analysis procedure. The gamma analysis handles the dose reference as a number of 
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points (refereed total points), so when the gamma analysis was run, the graphical output provided 
a number of passed point (the points less than or equal to the gamma value) and a number of failed 
points (the number of points greater than the gamma value.). The gamma pass rate is the ratio of 
the passed points to total points. For a 3DCRT field from 1 cm, most of the points were failed, and 
the gamma pass rate was low. Therefore, increasing the magnitude of variation slowed down the 
failing rate, as shown in Table 5.2. 
Table 5.2: Gamma analysis details with 3DCRT field for increasing in the magnitude of tissue variations. 
Magnitude 
variation 
Total point Pass point Fail point Gamma pass rate (%) 
1 4255 3117 1138 73.30 
2 4220 2328 1892 55.20  
3 4192 2299 1893 54.80 
4 4195 2170 2025 51.70 
* Variation noted in total points consider from the uncertainty of gamma analysis 
 
5.4.3 Global & Local Criteria 
Although local gamma analysis yields a lower gamma pass rate, this finding demonstrated 
that using local analysis does not increase the sensitivity of the EPID for detection of a minimum 
positional variation and lung variations. The lower pass rate arising from using local gamma 
analysis compare to global gamma analysis was expected. The reason was because the 
normalization of the dose difference to a maximum dose value hides errors in the lower dose 
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region, and the selection of this approach in the clinical setting is justified by “clinical relevance” 
[92].  
For positional variations in the H&N treatment site, the lowest pass rate using local gamma 
analysis corresponded to 4 mm rather than 5 mm. This trend was not noticed with global analysis 
or with the lung treatment site. The H&N is composed of high beam obliquity (air bone interfaces) 
when compared with the lung (air cavity); hence, differential attenuation due to interface is more 
likely in H&N compared with lung sites. The maximum dose difference can be expected in the 
H&N with a 4 mm shift. Global gamma with the H&N eventually excludes the higher dose points 
within a 10% threshold. 
5.4.4 Relaxation & Tighter Criteria 
This study examined various gamma criteria from 3%/3mm to 1%/1mm in order to 
determine the optimal criteria. To our knowledge, no studies have yet utilized the EPID to detect 
patient variations with varying gamma criteria. The main finding was that a decrease in the distance 
to agreement tolerance optimizes the sensitivity of the EPID more than a tolerance of dose. This 
could be due to an advantage of EPID, as it is a high-resolution detector. Furthermore, the study 
shows the optimal criterion is 3%/1 mm, as the EPID with this criterion could detect most of the 
tested variations. The performance of the EPID with this criterion did not depend on the delivery 
technique or the variation type. As expected, a criterion of 1%/1 mm showed a generally superior 
performance for detecting patient variations and was able to detect all variations introduced in this 
study. However, the clinical use of this criterion is still debated because gamma analysis with a 
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criterion of 1%/1 mm has been reported to produce dosimetric errors and statistical fluctuations 
[195].  
For anatomical lung variations, the EPID using various gamma criteria cannot detect 
variations up to 4 cm, except when using a gamma criterion of 1%/1 mm. The reason for the failure 
of the EPID to detect these variations with a criterion such as 3%/1 mm is that the dose difference 
arising from lung variations was less than 2%. Therefore, reducing the dose tolerance to 1% is 
required to detect this variation. 
5.4.5 Structural Similarity Index 
A difference was demonstrated between the image- based evaluation method (SSIM) and 
a typical dose-based evaluation method (gamma analysis) using the EPID. With the SSIM index, 
the sensitivity of the EPID increases to enable detection of small variations, such as a 2 mm 
variation in position or a 1 cm of lung anatomical variation. Unlike gamma analysis, the EPID 
using the SSIM index has a higher sensitivity for lung compared to H&N treatment sites, and for 
dIMRT compared to 3DCRT fields. This could be because the SSIM index computes the contrast 
between images. The contrast will be more dominant in bony structures in the H&N than in the air 
cavities in lung sites, and the contrast is greater in the dIMRT field (no uniform intensity) than in 
the 3DCRT (uniform intensity) field.  
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5.4.6 Limitations 
The EPID transit dosimetry system evaluated in this study is not a stand-alone tool meant 
to detect all sources of error. In addition, if an error is detected, an alternative method to evaluate 
the clinical relevance of these errors is required.  
This study is a phantom based study. For positional variations, the error was introduced in 
one direction. In the clinic, this error could be also be a rotational and/or translational shift. For 
anatomical variations, material that mimics tissue changes in the slab phantom were used; 
however, a in reality, a scenario of changing anatomy will not be a uniform change in one kind of 
material. In addition, the test fields were selected so that the field area was always contained within 
the EPID active area without having to re-position the panel away from the beam center in the 
lateral or longitudinal directions. 
A gamma pass rate detection should also be further optimized to meet the specific demands 
for radiotherapy protocols, as one gamma pass rate may not be sufficient for all clinical scenarios 
(3DCRD, dIMRT).  
The purpose of using the SSIM in this work was to confirm the ability of this tool to detect 
variations that cannot be detected using gamma analysis. However, interpretation of the error 
outcomes from SSIM may require further work to optimize the SSIM algorithm parameters.  
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5.5 Conclusion 
Transit measurements during the course of patient treatment aids in the detection of 
variations that could occur between fraction and monitor treatments. This will have a significant 
potential to improve patient safety. This work demonstrated EPID based transit dosimetry during 
the course of treatment after the first fraction as a promising detection tool for variations during 
the course of treatment. In addition, the sensitivity of EPID based transit dosimetry for detecting 
the positional and anatomical variations were examined using gamma analysis. The use of gamma 
analysis indicated that the sensitivity of EPID transit dosimetry for patient variations depends on 
the treatment site, the type of delivery technique, and the tissue heterogeneities. The gamma 
analysis tool revealed that the main factor that optimized the sensitivity of EPID was reducing the 
tolerance of the distance to agreement. The more sensitive criterion is 3%/1 mm, and it does not 
depend on the type of delivery technique or the type of variation. However, gamma analysis has 
limitations of a minimal positional variation of 2 mm and in detecting anatomical lung variations. 
The study presented in this chapter offers baseline information about the use of the SSIM index as 
an alternative analysis method that has higher sensitivity for these variations. 
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Chapter 
 
6 Measure Beam Attenuation through a 
Couch and Immobilization Devices 
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6.1 Introduction 
In radiotherapy treatments, immobilization devices serve to allow reproducible setup of the 
patient throughout their treatment [196]. Whilst these immobilization and support devices are 
essential for the spatial accuracy of the delivery, the devices attenuate the incident beam and 
therefore affect the dose received by the target. The impact of these support and immobilization 
structures has become a particular area of interest with the introduction of arc delivery techniques 
because a significant portion of the target dose is delivered through the couch top and rails if 
present. In addition, the increased use of carbon fibre couch tops, which are ideal for imaging 
purposes to verify patient position, may not be ideal for treatment, particularly, when the support 
structures such as the rails are within the beam portal [197]. 
 Recent studies show that the failure to account for beam attenuation through the treatment 
couch and immobilization devices can have a dosimetric impact. For example, Mihaylov et al. 
[198] reported an increase in skin dose of 68% and 80% of the prescription dose for VMAT plan 
with 6 and 18 MV photon energies, respectively. Li et al. [199] showed the maximum dose 
difference was 2.6% between treatment plans delivered with and without the existence of the 
sliding rails in the beam direction for two IMRT and two VMAT treatments. 
 In addition, the overall beam attenuation magnitude through couch and immobilization 
devices is variable based on the structure of the couch and immobilization device used, and, is 
function in field size, beam energy, gantry angle and the portion of beam pass through devices 
[197]. For example, beam attenuation of up to 15% was reported for an Exact treatment couch 
(Varian) when the beam passes through a movable couch rail [50]. Attenuation varied from 2% to 
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5% for  iBeam EVO type (Elekta) based on the angle of incidence of the treatment beam [200]. In 
addition to the couch structure, beam attenuation caused by immobilization devices such as lung, 
head and neck devices has been reported as ranging from 3%  to 10% [151].  
A recent review paper by the AAPM group Task Group 176 (2014) emphasized that 
attenuation measurements are required to validate the TPS modelling for couch and 
immobilization devices, for use in independent MU calculation, and to verify values supplied by 
the manufacturers for these devices. Furthermore, it was recommended  that if the TPS are not able 
to model attenuation caused by couch and immobilization device it is essential to obtain attenuated 
data for typical as well as worst case clinical conditions for beam attenuation [197].  
The conventional approach to measure beam attenuation is by using an ionization chamber 
inserted into a phantom placed on the couch with no clear consensus in the literature on the 
phantom design [199, 201-211]. Typically, ionization chambers measure beam attenuation only in 
the centre of the field whereas the couch and immobilization devices are a non-homogenous 
structure. Moreover, an ionization chamber does not quantify the attenuation directly and only 
gives an estimate of the dose perturbation at the depth in a phantom [197]. There are limited studies 
in the literature regarding potentially more useful 2D beam attenuation measurements. Studies 
have used a radiographic film [212], 2D array of ion chambers (MatriXX) [213] and EPID (CCD-
camera based) that was clinically used as a dosimeter calibrated against 2D ionization chamber 
measurements [151]. These studies provide the entire 2D attenuated images that can validate the 
TPS modelling for couch and immobilization devices. However, the current practice of 1D 
measurement at the centre of field and the entire 2D attenuated image could not accurately estimate 
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the attenuation values for purposes such as independent MU calculation. Furthermore, with the 
increased use of arc delivery techniques, a 2D assessment provides a more robust and clinically 
relevant assessment of the dosimetric impact of these devices. 
In this work, we propose a simple and fast method to measure beam attenuation using 
amorphous silicon EPID detector (a-Si EPID) without the requirement to convert the EPID 
response to a water equivalent response. Unlike previous approaches, the proposed method allows 
use of either 2D (the attenuated image), or 1D (the mean of attenuated image). 
6.2 Method 
Two S500 EPIDs mounted onto two Varian linear accelerator 21iXs (Palo Alto, USA) were 
irradiated at SDD of 150 cm. The center of the EPID active matrix was located on the central axis 
of the beam for all measurements. Measurements were performed using couches (an Exact couch 
top, an IGRT couch). An Exact couch consists of couch top and two translatable sliding rails. 
Measurements were evaluated with the sliding rails were removed away from the beam direction. 
This mimics the clinical case where the rails are usually positioned outside the beam’s field size. 
The immobilization devices examined were a Foamedic Bellyboard 6-8 cm blue covered foam 
(CIVCO Radiotherapy, USA), and Head and Neck Base Board with Timo Med Tech Neck shape 
B (CIVCO Radiotherapy, USA). Measurements were acquired with a delivery of 100 MU with a 
photon beam of 6 MV and a dose rate of 600 MU/min unless otherwise specified. Image 
Acquisition Software (IAS3, version 8.2.03) was used to acquire EPID images. Images were 
acquired using integrated acquisition mode. 
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6.2.1 Validation of the EPID Measurements 
To validate EPID based beam attenuation measurements, a comparison to an ionization 
chamber measurement (Thimble chamber CC13, Scanditronicx Wellhofer, IBA) in combination 
with an electrometer was used. Ionization chambers were positioned on the central axis at a depth 
of 1.5 cm at source to ionization chamber distance of 150 cm for a photon energy of 6 MV. Beams 
at normal incidences were delivered using 100 MU and a field size of 5×5 cm2 to minimize any 
scatter effects [151]. Measurements were carried out for an open beam, a beam through the Exact 
couch top, and a beam through a homogeneous solid water slab phantom of 2 cm and 4 cm thick 
(RW3, PTW). These measurements were then repeated using the EPID.  
6.2.2 Beam Attenuation Measurement using EPID 
First, a set of images was acquired for the open beam without the presence of the treatment 
couch, which is designated V!WXYZ[\57].		Images of jaw defined square fields of side: 5, 10, 15, 
20 cm, delivering 100 MU using a photon beam of 6 MV at gantry degree zero were acquired.  A 
second set of images was acquired for the scenario in which the beam passed through the couch or 
immobilization device(!WXYZ^_`ab). Measurements were performed through the Exact couch, 
IGRT couch, the combination of Exact couch and belly board, and the combination of Exact couch 
and head and neck baseboard ( illustrated in Figure 6.1). Each series of measurement through the 
support structures was conducted for jaw defined square fields of side: 5, 10, 15, 20 cm at gantry 
angles of 0, 30, 60°. No measurements were conducted in other gantry directions since the 
assumption was that any angular dependence would be symmetric. The couch was positioned at 
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SSD of 110 cm and immobilization devices were positioned according to clinical usage. 
Measurements were repeated two times and beam attenuation was computed as the ratio of the 
measurement with the couch in place (attenuated beam) to that of the un-attenuated beam. 
Averaged attenuation is reported as a percentage plus or minus 1SD.  
 
 
Figure 6.1: Illustration of experiment setup. EPID positioned at source to detector distance (SDD) of 150 
cm and couch positioned at SSD of 110 cm. Beam attenuation measurement conducted using Exact couch top 
without sliding rails, IGRT couch, Head and Neck Base Board and Bellyboard. 
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6.2.3 Beam Attenuation Dependency 
6.2.3.1 Field Size Dependency 
!WXYZ[\57	Xcd	!WXYZ^_`ab	with and without Exact couch top for jaw-defined square 
fields of side: 5, 10, 15 cm at gantry angles of 0 and 60° were acquired for a photon beam of 6 MV 
with a delivery of 100 MU.  
6.2.3.2 Photon Energy Dependency 
!WXYZ[\57	Xcd	!WXYZ^_`ab	were acquired with and without the Exact couch top for 
delivering 100 MU using a photon energy of 6 and 18 MV, respectively. !WXYZ[\57measurements 
were taken for jaw defined square fields of side: 5, 10, 15 cm at gantry angles of 0°.  To measure 
the 18 MV beam, the thickness of 2.5 mm of Cu sheet was added on the EPID panel. Thickness 
was determined according to the method by Sabet et al. [135]. This method includes varying the 
air gap between phantom (20 cm of solid water slab) and EPID using a slab of build-up material 
until a consistent response of EPID and ionization chamber was obtained. This was done as it was 
reported that EPID required external build up material for dosimetry purposes for a photon energy 
of 18 MV [30]. 
6.2.3.3 Couch Thickness Dependency 
The IGRT couch has variable thickness, from the couch thickness region defined at 
the pelvis (thick) and head (thin) regions, connected by a transition (medium) region [214] , (See 
Figure 6.1 picturing the different thickness of IGRT couch ). !WXYZ[\57	Xcd	!WXYZ^_`ab were 
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acquired with and without IGRT couch positioned at SSD of 110. Measurements were performed 
for jaw-defined square fields of side10 cm at gantry angles of 0 °. 
6.2.3.4 Phantom Dependency 
In the clinical scenario, a patient would be present on the treatment couch and therefore 
measurements with a phantom mimicking the patient were taken. For the reference, un-attenuated 
images, measurements were taken with 20 cm of solid water resting on the couch rails extended 
without the couch present. Images with collimated beams of side length 5, 10 and 15 cm were 
acquired for beam energy of 6 MV with 100 MU, respectively.  The same measurements were then 
repeated with the couch in place, See Figure 6.2.  
 
Figure 6.2: Measurement using phantom supported by sliding rail without couch grid to aquire !WXYZ[\57  
, and phantom supported by couch top to aquire 	!WXYZ^_`ab .EPID at SDD 150 cm and couch at SSD 110 cm. 
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6.2.4 Data Analysis  
Images acquired were analysed using MATLAB (VR2012b, the MathWorks, Natick, MA). 
Attenuated images were derived by computing the percentage difference between measurements 
made with and without the presence of the couch or immobilization devices, according to the  
following equation [202]:  
2:	fggZchXggZd	!WXYZ	% = 	 (46j5	klHm/(46j5	nopqr(46j5	klHm 	× 	100    (4) 
In each 2D attenuated image, the percentage attenuation at the centre, mean and maximum 
were reported. The centre of attenuated image was assessed as the average of 11×11 pixels at the 
centre of field. The mean of attenuated image was taken as the mean pixel value within 80% of 
the field size. The maximum of the attenuated image was reported as the highest value within the 
field. 
6.3 Results 
6.3.1 Validation of the EPID Measurements 
A comparison of beam attenuation through couch top and solid water slabs as measured 
using ionization chamber and EPID is reported in Table 6.1 was initially conducted. Results shows 
beam attenuation using EPID were similar to ionization chamber results within ± 0.1 to 1.4 (1 SD).  
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Table 6.1: Beam attenuation measurements using an ionization chamber and EPID, with 100 MU of 6 MV 
photons and a field size of 5´5 cm2, EPID measurement values are derived from the centre pixel of the attenuated 
image.  
Material  Ionization 
chamber  
EPID  
Couch top 3.0 % 3.2 % 
Solid water of 2 cm 9.6 % 10.5 % 
Solid water of 4 cm 18.3 % 20.3 % 
 
6.3.2 Beam Attenuation Measurements using EPID 
The magnitude of beam attenuation measured by the EPID through the Exact couch, IGRT 
couch, the combination of Exact couch and belly board, and the combination of Exact couch head 
and neck baseboard is shown in Figure 6.3. Beam attenuation was expressed as a percentage 
comparison for centre and the mean of the attenuated image to that of the unattenuated beam. Error 
bars represent the standard deviation from repeated measurements and were within ± 0.02% and ± 
0.16% (1 SD), respectively. Overall, at the normal incidence (gantry degree 0°), the highest beam 
attenuation was observed through the combination of the exact couch and head and neck 
baseboard, yielding a 9.6%  ± 0.03% (1 SD) reduction when using the mean of the image. The 
least attenuation was found for the IGRT couch, with a 2.5% ± 0.01% (1 SD) reduction. As 
expected, beam attenuation was increased by increasing beam obliquity due to the path length 
through the couch increasing. The two greatest attenuation measurements were found for the 
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combination of Exact couch and belly board with 11.2%  ± 0.08% (1 SD), and the combination of 
Exact couch and head board of 10.9 % ± 0.05% (1 SD) at 60 degrees incidence. The Exact couch 
showed a more oblique dependency compared to the IGRT couch. When the beam obliquity 
changed from 0 to 60° the relative beam attenuation increased by 3.1% for the Exact couch, and 
by 1.5% for the IGRT couch.  
When comparing the difference in the value of the beam attenuation using the method of 
the central pixel and the mean pixel value within 80% of the field size, results in Figure 6.3 show 
that for an attenuated beam with an IGRT couch, the difference between the centre pixel and the 
mean pixel value methods was 0.1%. Whereas, for the Exact couch, the difference between the 
centre pixel and mean pixel value respectively was 0.8% at an oblique beam incidence. The 
differences between the centre and the mean of an attenuated image increased noticeably to 
approximately 1.8% in the presence of an immobilization device. In most cases, the beam 
attenuation assessment using the mean of the attenuated image was higher than the centre. For 
example, at normal incidence the combination of couch and head board attenuated the beam up to 
9.6% ± 0.03% (1 SD) and 7.8% ± 0.03% (1 SD) using the mean and centre of attenuated images 
respectively. 
 When using the maximum percentage of the attenuated image, a maximum value of up to 
26.2% was noticed for a combination of Exact couch and head board at gantry degree 60° (Table 
6.2).  
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Figure 6.3: Beam attenuation assessment using centre and mean pixel value of attenuated images, centre is 
represented by a solid symbol and mean is an open symbol, each data point is the average of the four field size 
measurements of 5, 10, 15, 20 cm using 6 MV, and couches were positioned at 110 cm SSD. Error bars are the same 
size or smaller than the symbols used. 
Table 6.2: Example of measurement of the maximum percentage of attenuated images, measurements with 
couch position at SSD 110 cm using a photon beam of  6 MV and a field size of 10´10 cm2. 
Setup Maximum attenuation %   
Gantry 0° Gantry 30° Gantry 60° 
Exact couch  4.99% 5.78% 11.32% 
IGRT couch  2.95% 4.48% 10.74% 
 Exact couch and belly board  14.92% 15.30% 20.80% 
Exact couch and Head board   11.61% 18.14% 26.22% 
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6.3.3 Beam Attenuation Dependency 
6.3.3.1 Field Size Dependency 
The attenuation as a function of field size through the Exact couch was measured (Figure 
6.4). A decrease in beam attenuation was noticed with an increase in field size, particularly, with 
an oblique beam incidence. Attenuation reduced within 1% ± 0.03% (1 SD) and 2.1% ± 0.02% (1 
SD) for the centre and mean of attenuated images respectively when the side of the field increased 
from 5 to 15 cm. One outlier was observed when the attenuation measured for a field size of 15x15 
cm2 using the mean of an attenuated image for normal incidence. There was no difference between 
the centre and the mean of an attenuated image using a 5×5 cm2 field size while differences appear 
with the increase field size up to 1.13% ± 0.1% (1 SD) for an oblique incidence. 
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Figure 6.4: Beam attenuation through exact couch top as a function of field size for normal and oblique 
beam incidences, measurements at source to couch distance of 110 cm using a photon beam of 6 MV. Error bars are 
the same size or smaller than the symbols used. 
6.3.3.2 Photon Energy Dependency 
Beam attenuation measurements as a function of photon energy are shown in in Figure 6.5. 
The attenuation of 18 MV photon beams was less compared to 6 MV by 1.1% and 1.9% for a field 
size of 5×5 cm2   and 15×15 cm2, respectively. 
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Figure 6.5: Attenuation measurement as a function of photon energy using the centre and mean of 
attenuated image, measurements with positioned Exact couch top at 110 cm. Error bars are the same size or smaller 
than the symbols used. 
6.3.3.3 Couch Thickness Dependency 
Attenuation through the IGRT couch, when the beam passed different regions of the IGRT 
couch, was measured (Figure 6.6). The varying thickness of the different regions caused a variation 
in the magnitude of the attenuation, dependant on the region, and varying by up to 1.8%.  For a 
thick (pelvis) region, beam attenuation was within 4.14% and 3.83% based on field size. For a thin 
(head) region, beam attenuation was within 2.3 and 2.71%. 
163 
 
 
Figure 6.6: Attenuation measurement through IGRT couch as a function of passed thickness  energy using 
mean of attenuated image, measurements with positioned IGRT at 110 cm. Error bars are the same size or smaller 
than the symbols used. 
6.3.3.4 Phantom Dependency 
The effect of including a phantom on beam attenuation is shown in Figure 6.7. 
Interestingly, the amount of attenuation was reduced in the presence of the phantom from 3.4% to 
2.2% for a large field size of 15×15 cm2, with the reduction being field size dependent. 
 
 
 
 
164 
 
 
Figure 6.7: Attenuation data with and without the exsitence of 20 cm solid water phantom, measurements 
for jaw defined field using a beam  energy of 6 MV with gantry angle zero and Exact couch position of 110 cm. 
Error bars are the same size or smaller than the symbols used. 
6.4 Discussion  
Measurements of attenuation through couch and immobilization devices are relative and 
do not need absolute values [215] enabling the EPID to be used to efficiently characterise new 
couch structures and immobilization devices. An EPID based measurement, such as the method 
outlined in this study also has the capability to provide 2D attenuation maps as well as 1D 
attenuation maps without any modification to convert EPID responses to water equivalent 
responses. The proposed method allows the user to either use 2D attenuated images to determine 
typical and worst-case attenuation conditions, representative of clinical conditions, and validate 
the predictions of the TPS. The mean of the 2D attenuation map can also be used in independent 
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MU calculations to enhance the comparison and calculation validity. Finally, the method provides 
an easy way to compare measurements to manufacturer’s data at the time of commissioning. The 
process presented in this chapter is also faster to perform, taking only a few minutes to capture 
images and calculate the attenuation. The method could also be applied to any EPID vendor. In 
addition, this study  examined the 2D beam attenuation in a variety of geometrical scenarios while 
a few limited studies have only evaluated the impact of gantry angle and field size using 1D 
dosimetry  [199, 215]. Furthermore, with the increased use of an EPID for transit dosimetry, this 
study could be useful to quantify attenuation arising from treatment couch and immobilization 
devices on EPID images, and could be used to estimate the correction factors associated with 
transit dosimetry.  
The similarity between EPID images and ionization chamber attenuation measurements 
provides validation for the suitability of using an a Si- EPID to assess the beam attenuation through 
couch and immobilization devices. These results confirmed previous data collected using a CCD 
camera-based system [151].  
Beam attenuation increased with increased obliquity of the beam as shown in Figure 6.3. 
This finding confirms previous results using ionization chamber. The reason for increased 
attenuation with an increase in obliquity of the beam may be explained by the  increased beam 
path length through the attenuator [199, 215]. In addition, results in Figure 6.3 demonstrate an 
angular dependence for the Exact couch compared to the IGRT couch. This indicates the structure 
of IGRT couch may be more homogenous than the Exact couch. Moreover, with the involvement 
of immobilization devices, attenuation assessed by the mean of the image was higher than the 
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centre. This is because the immobilization device is non-homogeneous, which can be seen in the 
data presented in Figure 6.8. The results presented in this chapter have highlighted the fact that the 
conventional approach to measuring attenuation in the centre of field may be insufficient, with a 
2D measurement providing additional information on the spatial variation of attenuation which 
could be important for inhomogeneous couch structures.  
 
Figure 6.8: Attenuated image through the combination of Exact couch and head and neck baseboard at 
normal incidence using a photon energy of 6 MV and a field size of 20´20 cm2.  
For field size dependency, results presented in this work show the attenuation reduced with 
an increase in field size. This is consistent with results  in a previous study which reported that the 
reduction was within 1 to 2% using an ionization chamber, and explained due to the effect of 
scatter radiation [215]. As shown in Figure 6.4, results obtained in this chapter demonstrated that 
with oblique beam incidence, the centre of an attenuated image was higher than the mean by 
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1.13%.  To explain these results, attenuated images for oblique beam are shown as a function of 
field size in Figure 6.9. An attenuated image with a smaller field size shows that the couch 
attenuates all the entirety of the incident beam, therefore the value of attenuation at the centre of 
field and mean attenuation were similar. In contrast, with an increase in field size and beam 
obliquity, the portion of the beam passing through the couch is less, therefore the attenuation value 
at the centre was higher while the attenuation value at the mean was less. These results highlight 
the importance of 2D mapping of the attenuation provided by modern patient support and 
immobilization devices.   
The results illustrated in Figure 6.8 show that higher differences appeared at the edge of 
the field.  This could be due to the effect of sagging of the EPID and collimator jaws during rotation 
[50]. 
A good example of the power of EPID as a measurement tool for attenuation is illustrated 
in Figure 6.6. EPID clearly can identify the differences in thickness of the IGRT couch. This 
highlighted the importance of individualized beam attenuation measurement based on the region 
of couch irradiated. 
Results depicted in Figure 6.7 indicate that with the existence of the phantom, the 
magnitude of attenuation was reduced. This could be due to increased scatter radiation, which 
consequently, reduces the attenuation.  
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Our results in Figure 6.5 demonstrated that build up materials are necessary to measure 
beam attenuation for 18 MV and the optimum build up thickness is 2.5 mm of Cu. The attenuation 
by the couch was greater with lower energy photons [215]. 
 
Figure 6.9: Attenuated images with oblique beam (60°) as function in field side of 5, 15 cm respectively 
using a photon energy of 6 MV and couch position at 110 cm. 
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6.5 Conclusion 
A simplified method of measuring beam attenuation through the treatment couch and 
immobilization devices using aS500 EPID is presented and validated against ionization chamber 
measurements. This approach is simple and fast and can provide attenuation data in 2D or 1D in a 
few minutes. We have quantified beam attenuation through Exact and IGRT couches and 
immobilization devices (belly board, head and neck baseboard) as a function of gantry angle and 
field size. Furthermore, attenuation measurements might be a useful tool/procedure to quantify the 
effect of attenuation arising from treatment couch and immobilization devices on EPID images 
when an EPID is used as transit dosimetry. 
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Chapter 
7 Conclusion and Future Work 
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The objective of this thesis was to extend the application of the EPID in two main areas, 
with the overall goal of providing a simple procedure that would use minimal resources and enable 
the use of the EPID in the clinical setting. The EPID was used in transit dosimetry and in 
measurement of beam attenuation through couch and immobilization devices. The relevance of 
this thesis is grounded in the ongoing popularity of the EPID in dosimetry applications due to the 
advantages the EPID has over other detectors, such as its high spatial resolution with a digital 
format, large imaging area, real-time acquisition, and the capability for 3D dose reconstruction. A 
further advantage of EPID is that it is attached to the linear accelerator, which results in a less 
burdensome clinical workload needed to set up the detector.  
The clinical use of the EPID in transit dosimetry applications is still in its early stages and 
is limited to a few centers around the world. This may reflect the complexity of reproducing the 
proposed method, and commercial solutions for clinical use are still in the assessment stage. 
Furthermore, investigations on the sensitivity of the EPID to patient variations using gamma 
analysis are limited in the literature. In the present study, the EPID images were acquired in the 
cine mode because this is a promising mode to utilize with advanced delivery techniques. A major 
limitation with this mode is its nonlinearity at low MU. We assessed the performance of this mode, 
particularly with delivery of a dose of low MU and with changing dose rates. This performance 
assessment is important since some delivery modalities can change the dose rate during delivery 
or can deliver low MU.  
The influence of cine mode use on the dosimetric characteristics of the EPID was examined 
and compared to the well-documented integrated mode. The worst nonlinearity was observed at 
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low MU settings of less than 100 MU with the highest dose per frame, which was attributed to 
failure to acquire four images in each delivery. For dosimetric applications, this effect could be 
minimized by calibration of the EPID images at a large MU. Furthermore, when the IMRT 
verification field has a low MU and a high dose rate, a correction for the missing images may be 
required. Missing images could be compensated by quantifying the dose equivalent for four images 
and then adding this dose to each field. For the dose rate change with low MU, the EPID response 
using a cine acquisition mode had a comparable response to the performance observed with an 
integrated mode and ionization chamber. Furthermore, the EPID performance showed similar 
responses (within 2%) when operated in the cine and integrated acquisition modes. Therefore, no 
additional corrections were required when the EPID was operated in the cine acquisition mode 
compared to when it was calibrated in the integrated mode. 
After examining the dosimetric characteristics of the cine mode, the EPID based 
measurement method proposed by Sabet et al. [135] was adapted. This approach involved 
calibration of 2D transit EPID images to 2D equivalent water image doses using ionization 
chamber measurements in a plane at the depth of the maximum dose at the level of the EPID. This 
method drew our attention since it was the only available measurement-based method that could 
be used without application of a kernel or a MC simulation. This is important because it means 
that it would be feasible to use in the clinic by persons with only average computer skills. However, 
the original method calibrated the EPID response at the in-field area using a number of corrections, 
including removal of the FF clinical calibration, application of PSM, combination of the effects of 
off-axis distance and phantom thickness, and combination of the effects of field size and phantom 
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thickness. We modified the Sabet method by a novel in-field area correction that allowed 
calibration of the in-field area of the EPID response in a single step, rather than through a number 
of corrections. After application of an in-field area correction, the EPID was in agreement with the 
ionization chamber profiles and with the MapCHECK transit dose planes for delivering clinical 
dIMRT fields. 
Transit measurements made during the course of patient treatment can aid in the detection 
of patient variations that might occur between the fractions, thereby facilitating treatment 
monitoring. Therefore, these measurements have a significant potential to improve patient safety. 
We demonstrated the feasibility and sensitivity of our transit EPID dosimetry to detect clinically 
relevant patient variations during the course of treatment after the first fraction. With the use of 
gamma analysis, the sensitivity of EPID transit dosimetry for patient variations depends on the 
treatment site, the type of delivery technique, and tissue heterogeneity. This highlights that the 
main factor for optimizing the sensitivity of the EPID is reducing the distance tolerance of the 
gamma criteria, and the optimal sensitive criterion is 3%/1 mm. Due to the limitations of gamma 
analysis to detect a minimal patient variation, the SSIM index was offered as an alternative analysis 
method that has higher sensitivity for these variations. 
A recent review paper by the AAPM group Task Group emphasized the necessity of beam 
attenuation measurements. However, the couch and immobilization devices are non-homogenous 
structures; hence, 2D measurement would provide additional information on the spatial 
distribution of the reduction in dose due to these structures. We demonstrated that the application 
of the EPID shows promise for measurements of beam attenuation through the couch and 
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immobilization devices. In this thesis, a simple tool that measures beam attenuation through patient 
support structures has been proposed and validated. The proposed method allows the use of either 
2D (the attenuated image) or 1D (the mean of the attenuated image). 
The findings of this thesis could be extended in a number of directions. For the dosimetric 
characteristics, in our study, the frame rate for the cine mode was 12.8 and 8.001 frame/sec for 
dose rates of 600 and 400 MU/min, respectively, and the number of frames per image was one. 
More investigations for optimization of the frame rate and the number of frames averaged per 
image could be important, and this could depend on the type of delivery technique. To develop 
EPID transit dosimetry, we have added an additional thickness of Cu sheet onto the EPID panel 
and used this for the rest of the experiments. Once a novel in-field area is developed, we believe 
this correction will compensate for the impact of the added Cu sheet. Therefore, the added Cu 
sheet will not be necessary, particularly for a photon energy of 6 MV. Further investigation without 
utilizing Cu sheet at a photon energy of 6 MV is required.  
For the sensitivity of the EPID, a recent study by Steers [216] using ArcCHECK dosimetry 
highlighted that increases in the dose threshold value can increase the sensitivity of the device. 
Therefore, the impact of using a different threshold (e.g. 20 or 50% rather than 10%) could be 
examined. In this study, the ability of SSIM to increase the sensitivity of the EPID was highlighted 
and with was possible to capture some errors that could not be detected by gamma analysis. The 
SSIM index depends on three components: luminance (L), contrast (c), and structural image 
quality (s), and α > 0, β > 0, and Υ > 0 are parameters used to adjust the relative importance of 
these three elements. In the present study, the default function in MATLAB was used. More study 
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is required to optimize each component and to derive a dose map for the differences between 
fractions.  
The SBRT delivery technique also depends on delivery of a high dose in a few fractions; 
therefore, monitoring patient variation is important with this delivery technique. The sensitivity of 
EPID transit dosimetry can be investigated with this technique. At this stage in the research, the 
cine mode has been examined for summation of the delivered dose and for determining inter-
fraction errors. A more important investigation will be to acquire the intra-fraction variation. This 
could be done by acquiring a number of frames in the first fraction and considering this as a 
reference dose. A frame-by-frame comparison would then provide information about intra-fraction 
variations. This approach will require full automation and a higher computer power to convert 
each frame to a dose and compare it to the reference frame.  
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Appendices 
Appendix A.1: Fitting data for Figure 4.4 
Thickness of Cu 
sheet (mm) 
Linear model Poly2 Goodness of fit 
0 
 
     f(x) = p1*x^2 + p2*x + p3 
Coefficients (with 95% confidence bounds): 
       p1 =   6.227e-05  (5.408e-05, 7.047e-05) 
       p2 =   -0.005095  (-0.005673, -0.004516) 
       p3 =       1.099  (1.09, 1.108) 
  SSE: 1.665e-08 
  R-square: 1 
  Adjusted R-square: 0.9999 
  RMSE: 0.000129 
0.55 
 
     f(x) = p1*x^2 + p2*x + p3 
Coefficients (with 95% confidence bounds): 
       p1 =   5.417e-05  (-4.731e-05, 0.0001556) 
       p2 =   -0.004138  (-0.0113, 0.003023) 
       p3 =       1.071  (0.9546, 1.188) 
  SSE: 2.551e-06 
  R-square: 0.9858 
  Adjusted R-square: 0.9574 
  RMSE: 0.001597 
1.65 
 
   f(x) = p1*x^2 + p2*x + p3 
Coefficients (with 95% confidence bounds): 
       p1 =   4.097e-05  (-4.364e-05, 0.0001256) 
       p2 =   -0.002901  (-0.008872, 0.00307) 
       p3 =       1.043  (0.9458, 1.14) 
  SSE: 1.774e-06 
  R-square: 0.9745 
  Adjusted R-square: 0.9234 
  RMSE: 0.001332 
2.2 
 
     f(x) = p1*x^2 + p2*x + p3 
Coefficients (with 95% confidence bounds): 
       p1 =    4.47e-05  (-8.046e-05, 0.0001698) 
       p2 =   -0.003122  (-0.01195, 0.00571) 
       p3 =       1.045  (0.9011, 1.189) 
SSE: 3.881e-06 
  R-square: 0.9537 
  Adjusted R-square: 0.8611 
  RMSE: 0.00197 
 
2.5 
 
     f(x) = p1*x^2 + p2*x + p3 
Coefficients (with 95% confidence bounds): 
  SSE: 8.091e-06 
  R-square: 0.9099 
196 
 
       p1 =   4.513e-05  (-0.0001356, 0.0002258) 
       p2 =   -0.003138  (-0.01589, 0.009615) 
       p3 =       1.045  (0.8372, 1.252) 
  Adjusted R-square: 0.7297 
  RMSE: 0.002845 
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Appendix A.2: Fitting data for Figure 4.7 
Field size (cm2) Linear model Poly1 Goodness of fit 
2 x 2      f(x) = p1*x + p2 
Coefficients (with 95% confidence bounds): 
       p1 =   -0.002506  (-0.00298, -0.002031) 
       p2 =       1.496  (1.399, 1.592) 
  SSE: 6.379e-05 
  R-square: 0.9327 
  Adjusted R-square: 0.9259 
  RMSE: 0.002526 
 
5 x 5 
 
     f(x) = p1*x + p2 
Coefficients (with 95% confidence bounds): 
       p1 =  -0.0007361  (-0.0007919, -0.0006804) 
       p2 =        1.14  (1.128, 1.151) 
SSE: 0.02619 
  R-square: 0.9522 
  Adjusted R-square: 0.9509 
  RMSE: 0.02697 
 
 
8 x 8 
 
     f(x) = p1*x + p2 
Coefficients (with 95% confidence bounds): 
       p1 =  -0.0004361  (-0.0004559, -0.0004163) 
       p2 =       1.085  (1.08, 1.089) 
SSE: 0.0002145 
  R-square: 0.965 
  Adjusted R-square: 0.9645 
  RMSE: 0.00175 
10 x10 
 
    f(x) = p1*x + p2 
Coefficients (with 95% confidence bounds): 
       p1 =  -0.0002908  (-0.0003029, -0.0002786) 
       p2 =       1.056  (1.053, 1.058) 
SSE: 0.0001828 
  R-square: 0.9633 
  Adjusted R-square: 0.9629 
  RMSE: 0.001458 
12 x12 
 
f(x) = p1*x + p2 
Coefficients (with 95% confidence bounds): 
       p1 =  -0.0002978  (-0.0003144, -0.0002813) 
       p2 =       1.061  (1.057, 1.065) 
SSE: 0.000777 
  R-square: 0.923 
  Adjusted R-square: 0.9223 
  RMSE: 0.002707 
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15 x15 
 
     f(x) = p1*x + p2 
Coefficients (with 95% confidence bounds): 
       p1 =  -0.0001302  (-0.0001367, -0.0001237) 
       p2 =       1.025  (1.024, 1.027) 
 
  SSE: 0.00032 
  R-square: 0.9207 
  Adjusted R-square: 0.9201 
RMSE: 0.001534 
20 x 20      f(x) = p1*x + p2 
Coefficients (with 95% confidence bounds): 
       p1 =  -0.0001302  (-0.0001367, -0.0001237) 
       p2 =       1.025  (1.024, 1.027) 
 
   SSE: 0.00032 
  R-square: 0.9207 
  Adjusted R-square: 0.9201 
  RMSE: 0.001534 
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Appendix A.3: Fitting data for  Figure 4.10 
Phantom 
Thickness (cm) 
Linear model Poly3: 
 
Goodness of fit 
0  
 
     f(x) = p1*x^3 + p2*x^2 + p3*x + p4 
Coefficients (with 95% confidence bounds): 
       p1 =   8.666e-06  (-7.236e-05, 8.969e-05) 
       p2 =   0.0003313  (-0.00124, 0.001903) 
       p3 =   -0.003851  (-0.01182, 0.004117) 
       p4 =      0.9994  (0.9894, 1.009) 
  SSE: 1.147e-05 
  R-square: 0.9983 
  Adjusted R-square: 0.9958 
  RMSE: 0.002395 
 
5 
 
     f(x) = p1*x^3 + p2*x^2 + p3*x + p4 
Coefficients (with 95% confidence bounds): 
       p1 =    2.41e-05  (-6.038e-05, 0.0001086) 
       p2 =   0.0006992  (-0.0009391, 0.002337) 
       p3 =   -0.002057  (-0.01036, 0.00625) 
       p4 =           1  (0.9896, 1.01) 
 
  SSE: 1.247e-05 
  R-square: 0.9984 
  Adjusted R-square: 0.996 
  RMSE: 0.002497 
 
 
10 
 
     f(x) = p1*x^3 + p2*x^2 + p3*x + p4 
Coefficients (with 95% confidence bounds): 
       p1 =   2.025e-05  (-8.7e-05, 0.0001275) 
       p2 =   0.0006333  (-0.001447, 0.002713) 
       p3 =   -0.002848  (-0.0134, 0.007699) 
       p4 =           1  (0.9868, 1.013) 
 
SSE: 2.01e-05 
  R-square: 0.9978 
  Adjusted R-square: 0.9945 
  RMSE: 0.00317 
 
15 
 
     f(x) = p1*x^3 + p2*x^2 + p3*x + p4 
Coefficients (with 95% confidence bounds): 
       p1 =   3.551e-05  (-1.146e-05, 8.248e-05) 
       p2 =   0.0008937  (-1.721e-05, 0.001805) 
       p3 =   -0.002319  (-0.006938, 0.0023) 
       p4 =           1  (0.9943, 1.006) 
  SSE: 3.855e-06 
  R-square: 0.9996 
  Adjusted R-square: 0.999 
  RMSE: 0.001388 
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20 
 
     f(x) = p1*x^3 + p2*x^2 + p3*x + p4 
Coefficients (with 95% confidence bounds): 
       p1 =   1.579e-05  (-7.855e-05, 0.0001101) 
       p2 =   0.0005623  (-0.001267, 0.002392) 
       p3 =   -0.003691  (-0.01297, 0.005586) 
       p4 =      0.9998  (0.9882, 1.011) 
SSE: 1.555e-05 
  R-square: 0.9985 
  Adjusted R-square: 0.9964 
  RMSE: 0.002789 
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Appendix A.4: Fitting data for Figure 4.12 
Field size (cm2) Linear model Poly2: Goodness of fit 
5 x 5      f(x) = p1*x^2 + p2*x + p3 
Coefficients (with 95% confidence bounds): 
       p1 =  -6.857e-07  (-5.382e-05, 5.245e-05) 
       p2 =   0.0003001  (-0.0008082, 0.001408) 
       p3 =     0.01253  (0.007848, 0.0172) 
  SSE: 2.669e-06 
  R-square: 0.8848 
  Adjusted R-square: 0.7697 
  RMSE: 0.001155 
10 x 10 
 
     f(x) = p1*x^2 + p2*x + p3 
Coefficients (with 95% confidence bounds): 
       p1 =  -1.143e-06  (-2.913e-05, 2.685e-05) 
       p2 =   0.0004549  (-0.0001289, 0.001039) 
       p3 =      0.0301  (0.02764, 0.03257) 
  SSE: 7.406e-07 
  R-square: 0.9844 
  Adjusted R-square: 0.9688 
  RMSE: 0.0006085 
 
15 x 15 
 
     f(x) = p1*x^2 + p2*x + p3 
Coefficients (with 95% confidence bounds): 
       p1 =   2.629e-06  (-4.712e-05, 5.238e-05) 
       p2 =    0.000477  (-0.0005605, 0.001515) 
       p3 =     0.04675  (0.04237, 0.05113) 
SSE: 2.339e-06 
  R-square: 0.9677 
  Adjusted R-square: 0.9355 
  RMSE: 0.001082 
 
20 x 20 
 
  f(x) = p1*x^2 + p2*x + p3 
Coefficients (with 95% confidence bounds): 
       p1 =   6.857e-06  (-1.569e-05, 2.94e-05) 
       p2 =   0.0004549  (-1.541e-05, 0.0009251) 
       p3 =       0.056  (0.05402, 0.05799) 
SSE: 4.806e-07 
  R-square: 0.9946 
  Adjusted R-square: 0.9891 
  RMSE: 0.0004902 
 
 
